10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)
x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2018
OR
¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM             TO

Commission file number: 001-37401

Community Healthcare Trust Incorporated

(Exact Name of Registrant as Specified in Its Charter)

Maryland (State or Other Jurisdiction of Incorporation or Organization) 46-5212033 (I.R.S. Employer Identification No.)

3326 Aspen Grove Drive

Suite 150

Franklin, Tennessee 37067

(Address of Principal Executive Offices) (Zip Code)

(615) 771-3052

(Registrant’s Telephone Number, Including Area Code)

Not Applicable

(Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  x     No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  x     No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated  filer ¨ Accelerated filer x Emerging-growth company x Non-accelerated filer ¨ (Do not check if a smaller reporting company) Smaller reporting  company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section13(a) of the Exchange Act. x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). 

Yes  ¨     No x

The Registrant had 18,179,799 shares of Common Stock, $0.01 par value per share, outstanding as of May 3, 2018.

1

COMMUNITY HEALTHCARE TRUST INCORPORATED

FORM 10-Q

March 31, 2018

TABLE OF CONTENTS

		Page
PART I.—FINANCIAL INFORMATION
Item 1.	Financial Statements (Unaudited)	3
	Condensed Consolidated Balance Sheets	3
	Condensed Consolidated Statements of Income	4
	Condensed Consolidated Statements of Comprehensive Income	5
	Condensed Consolidated Statement of Stockholders' Equity	6
	Condensed Consolidated Statements of Cash Flows	7
	Notes to Condensed Consolidated Financial Statements	8
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	20
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	27
Item 4.	Controls and Procedures	27
PART II.—OTHER INFORMATION		27
Item 1.	Legal Proceedings	27
Item 1A.	Risk Factors	27
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	27
Item 3.	Defaults Upon Senior Securities	27
Item 4.	Mine Safety Disclosures	28
Item 5.	Other Information	28
Item 6.	Exhibits	28
SIGNATURES		30

2

PART I. FINANCIAL INFORMATION

ITEM 1.    FINANCIAL STATEMENTS

COMMUNITY HEALTHCARE TRUST INCORPORATED

CONDENSED CONSOLIDATED BALANCE SHEETS

(Dollars in thousands, except per share amounts)

	(Unaudited)
	March 31, 2018			December 31, 2017
ASSETS
Real estate properties
Land and land improvements	$	46,066		$	44,419
Buildings, improvements, and lease intangibles	356,530			343,955
Personal property	116			112
Total real estate properties	402,712			388,486
Less accumulated depreciation	(41,052		)	(36,136		)
Total real estate properties, net	361,660			352,350
Cash and cash equivalents	2,285			2,130
Mortgage note receivable, net	10,633			10,633
Other assets, net	25,210			20,653
Total assets	$	399,788		$	385,766
LIABILITIES AND STOCKHOLDERS' EQUITY
Liabilities
Debt, net	$	111,385		$	93,353
Accounts payable and accrued liabilities	3,806			4,056
Other liabilities	4,987			4,983
Total liabilities	120,178			102,392
Commitments and contingencies
Stockholders' Equity
Preferred stock, $0.01 par value; 50,000,000 shares authorized; none issued and outstanding	—			—
Common stock, $0.01 par value; 450,000,000 shares authorized; 18,179,799 and 18,085,798 shares issued and outstanding at March 31, 2018 and December 31, 2017, respectively	182			181
Additional paid-in capital	324,918			324,303
Cumulative net income	6,647			4,775
Accumulated other comprehensive income	1,232			258
Cumulative dividends	(53,369		)	(46,143		)
Total stockholders’ equity	279,610			283,374
Total liabilities and stockholders' equity	$	399,788		$	385,766

See accompanying notes to the condensed consolidated financial statements.

3

COMMUNITY HEALTHCARE TRUST INCORPORATED

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

FOR THE THREE MONTHS ENDED MARCH 31, 2018 AND 2017

(Unaudited; Dollars in thousands, except per share amounts)

	Three Months Ended March 31,
	2018			2017
REVENUES
Rental income	$	9,635		$	6,618
Tenant reimbursements	1,440			1,128
Mortgage interest	—			261
Other operating	354			—
	11,429			8,007
EXPENSES
Property operating	2,364			1,738
General and administrative	1,193			770
Depreciation and amortization	4,916			3,924
Bad debts	—			67
	8,473			6,499
OTHER INCOME (EXPENSE)
Interest expense	(1,268		)	(597		)
Interest and other income, net	184			2
	(1,084		)	(595		)
NET INCOME	$	1,872		$	913
NET INCOME PER COMMON SHARE:
Net income per common share – Basic	$	0.09		$	0.07
Net income per common share – Diluted	$	0.09		$	0.07
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING-BASIC	17,573,683			12,686,183
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING-DILUTED	17,573,683			12,819,496
DIVIDENDS DECLARED, PER COMMON SHARE, DURING THE PERIOD	$	0.3975		$	0.3875

See accompanying notes to the condensed consolidated financial statements.

4

COMMUNITY HEALTHCARE TRUST INCORPORATED

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

FOR THE THREE MONTHS ENDED MARCH 31, 2018 AND 2017

(Unaudited; Dollars in thousands)

			Three Months Ended March 31,
			2018		2017
NET INCOME			$	1,872	$	913
	Other comprehensive income (loss):
		Increase (decrease) in fair value of cash flow hedges	906		(158		)
		Reclassification for amounts recognized as interest expense	68		6
	Total other comprehensive income (loss)		974		(152		)
COMPREHENSIVE INCOME			$	2,846	$	761

See accompanying notes to the condensed consolidated financial statements.

5

COMMUNITY HEALTHCARE TRUST INCORPORATED

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY

(Unaudited; Dollars in thousands, except per share amounts)

	Preferred Stock		Common Stock		Additional Paid in Capital		Cumulative Net Income		Accumulated Other Comprehensive Income		Cumulative Dividends			Total Stockholders' Equity
Balance at December 31, 2017	$	—	$	181	$	324,303	$	4,775	$	258	$	(46,143	)	$	283,374
Stock-based compensation	—		1		615		—		—		—			616
Unrecognized gain on cash flow hedges	—		—		—		—		906		—			906
Reclassification adjustment for losses included in net income (interest expense)	—		—		—		—		68		—			68
Net income	—		—		—		1,872		—		—			1,872
Dividends to common stockholders ($0.3975 per share)	—		—		—		—		—		(7,226		)	(7,226		)
Balance at March 31, 2018	$	—	$	182	$	324,918	$	6,647	$	1,232	$	(53,369	)	$	279,610

See accompanying notes to the condensed consolidated financial statements.

6

COMMUNITY HEALTHCARE TRUST INCORPORATED

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited; Dollars in thousands)

	Three Months Ended March 31,
	2018			2017
OPERATING ACTIVITIES
Net income	$	1,872		$	913
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	5,133			3,998
Stock-based compensation	616			318
Straight-line rent receivable	(415		)	(265		)
Provision for bad debts, net of recoveries	—			67
Reduction in contingent purchase price	—			(5		)
Deferred income tax benefit	(132		)	—
Changes in operating assets and liabilities:
Other assets	(696		)	32
Accounts payable and accrued liabilities	(309		)	(578		)
Other liabilities	(121		)	75
Net cash provided by operating activities	5,948			4,555
INVESTING ACTIVITIES
Acquisitions of real estate	(12,721		)	(29,311		)
Acquisitions of notes receivable	(2,201		)	—
Proceeds from the repayment of notes receivable	17			140
Capital expenditures on existing real estate properties	(1,444		)	(64		)
Net cash used in investing activities	(16,349		)	(29,235		)
FINANCING ACTIVITIES
Net repayments on revolving credit facility	(22,000		)	(29,000		)
Term loan borrowings	40,000			60,000
Dividends paid	(7,226		)	(5,078		)
Debt issuance costs	(218		)	(766		)
Net cash provided by financing activities	10,556			25,156
Increase in cash and cash equivalents	155			476
Cash and cash equivalents, beginning of period	2,130			1,568
Cash and cash equivalents, end of period	$	2,285		$	2,044
Supplemental Cash Flow Information:
Interest paid	$	1,105		$	780
Invoices accrued for construction, tenant improvement and other capitalized costs	$	712		$	46
Increase (decrease) in fair value of cash flow hedges	$	906		$	(158	)

See accompanying notes to the condensed consolidated financial statements.

7

COMMUNITY HEALTHCARE TRUST INCORPORATED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2018

(Unaudited)

Note 1. Summary of Significant Accounting Policies

Business Overview

Community Healthcare Trust Incorporated (the ‘‘Company’’, ‘‘we’’, ‘‘our’’) was organized in the State of Maryland on March 28, 2014. The Company is a fully-integrated healthcare real estate company that owns and acquires real estate properties that are leased to hospitals, doctors, healthcare systems or other healthcare service providers in our target submarkets. The Company conducts its business through an UPREIT structure in which its properties are owned by its operating partnership (the "OP"), either directly or through subsidiaries. The Company is the sole general partner of the OP, owning 100% of the OP units. As of March 31, 2018, the Company had investments of approximately $413.3 million in 89 real estate properties, including a mortgage note, located in 27 states, totaling approximately 2.0 million square feet in the aggregate.

Basis of Presentation

The Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. They do not include all of the information and footnotes required by GAAP for complete financial statements.

This interim financial information should be read in conjunction with the financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017.

Management believes that all adjustments of a normal, recurring nature considered necessary for a fair presentation have been included. This interim financial information does not necessarily represent or indicate what the operating results will be for the year ending December 31, 2018. All material intercompany accounts and transactions have been eliminated.

Use of Estimates in the Condensed Consolidated Financial Statements

Preparation of the Condensed Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect amounts reported in the Condensed Consolidated Financial Statements and accompanying notes. Actual results may materially differ from those estimates.

Income Taxes

The Company has elected to be taxed as a real estate investment trust ("REIT"), as defined under the Internal Revenue Code of 1986, as amended (the "Code"). The Company and one subsidiary have also elected for that subsidiary to be treated as a taxable REIT subsidiary ("TRS"), which is subject to federal and state income taxes. No provision has been made for federal income taxes for the REIT; however, the Company may record income tax expense or benefit for the TRS to the extent applicable. The Company intends at all times to qualify as a REIT under the Code. The Company must distribute at least 90% per annum of its REIT taxable income to its stockholders (which is computed without regard to the dividends paid deduction or net capital gain and which does not necessarily equal net income as calculated in accordance with GAAP) and meet other requirements to continue to qualify as a REIT.

Effective January 1, 2018, under legislation from the Tax Cuts and Jobs Act of 2017, the maximum U.S. federal corporate income tax rate was reduced from 35% to 21%. Accordingly, to the extent that the activities of our taxable REIT subsidiary generates taxable income in future periods, it may be subject to lower U.S. federal income tax rates.

8

Notes to Condensed Consolidated Financial Statements - Continued

The Company classifies interest and penalties related to uncertain tax positions, if any, in the Condensed Consolidated Statements of Income as a component of general and administrative expenses.

New Accounting Pronouncements

In May 2014, the FASB issued Accounting Standards Update 2014-09, Revenue from Contracts with Customers ("ASU 2014-09"), which establishes a comprehensive model to account for revenues arising from contracts with customers. ASU 2014-09 applies to all contracts with customers, except those that are within the scope of other topics in the FASB's Accounting Standards Codification, such as real estate leases and financial instruments. ASU 2014-09 requires companies to perform a five-step analysis of transactions to determine when and how revenue is recognized. The Company adopted ASU 2014-09 using the "modified retrospective" method effective January 1, 2018; as such, the Company applied the guidance only to the most recent period presented in the financial statements. The primary source of revenue for the Company is generated through its leasing arrangements with its tenants, which is covered under other accounting guidance, but certain non-lease revenues could be impacted by the new guidance. While the Company has not historically sold any properties, accounting for the sales of real estate could also be impacted by this new guidance. Prior to the adoption of ASU 2014-09, gains and losses from real estate sales were adjusted at the time of the sale by the maximum exposure to loss related to continuing involvement with the real estate. After adoption, any continuing involvement is considered a separate performance obligation and the sales price is required to be allocated between the elements with continuing involvement and those without continuing involvement. As the continuing performance obligations are satisfied, additional gains and losses will be recognized. The Company recognized no change to previously reported amounts from the cumulative effect of the adoption of ASU 2014-09.

On January 1, 2018, the Company adopted ASU No. 2016-15, Statement of Cash Flows (Topic 230) Classification of Certain Cash Receipts and Cash Payments, ("ASU 2016-15"), which clarifies or provides guidance relating to eight specific cash flow classification issues. The standard should be applied retrospectively for each period presented, as appropriate. The impact of this new guidance will depend on future transactions, though the impact will only be related to the classification of those items on the statement of cash flows and will not impact the Company's total cash flows or its results of operations. There was no impact to the Company's Consolidated Financial Statements upon adoption of this standard.

On January 1, 2018, the Company adopted ASU No. 2017-09, Compensation - Stock Compensation (Topic 718), ("ASU 2017-09"), which provides guidance about which changes in the terms or conditions of a share-based payment award require a company to apply modification accounting in Topic 718. Under ASU No. 2017-09, a company will generally be required to apply modification accounting unless the fair value or intrinsic value of the modified award, the vesting conditions of the modified award, and the classification of the modified award as equity or a liability are the same as the original award immediately before the award is modified. There was no impact to the Company's Consolidated Financial Statements upon adoption of this standard.

In February 2016, the FASB issued ASU No. 2016-02, Leases, ("ASU 2016-02"). This standard requires a lessor to classify leases as either sales-type, finance or operating. A lease will be treated as a sale if it transfers all of the risks and rewards, as well as control of the underlying asset, to the lessee. If risks and rewards are conveyed without the transfer of control, the lease is treated as a financing lease. If the lessor doesn’t convey risks and rewards or control, an operating lease results. ASU 2016-02 is effective for fiscal years, and interim periods within, beginning after December 15, 2018. Early adoption is permitted. A modified retrospective transition approach is required for lessors for sales-type, direct financing, and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. Leasing revenues will continue to be recognized on a straight-line basis over the lease term, while certain reimbursable costs currently reflected on a net basis in the financial statements may require presentation on a gross basis under the new standard. Additionally, certain non-lease components may be accounted for under the new revenue recognition guidance in the Revenue ASUs. The Company may also be impacted by this new accounting guidance related to ground leases in which the Company would be the lessee. Pursuant to the new accounting guidance, lessees are required to record a right-of-use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. The Company is still evaluating the complete impact of the adoption of ASU 2016-02 on January 1, 2019 to its consolidated financial position, results of operations and disclosures.

9

Notes to Condensed Consolidated Financial Statements - Continued

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments-Credit Losses, ("ASU 2016-13"), which changes the impairment model for most financial assets and certain other instruments. For trade and other receivables, held-to-maturity debt securities, loans and other instruments, companies will be required to use a new forward-looking “expected loss” model that generally will result in the earlier recognition of allowances for losses. For available-for-sale debt securities with unrealized losses, companies will measure credit losses in a manner similar to what they do today, except that the losses will be recognized as allowances rather than as reductions in the amortized cost of the securities. Companies will have to disclose significantly more information, including information they use to track credit quality by year of origination for most financing receivables. Companies will apply the standard’s provisions as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is adopted. This standard is effective for the Company on January 1, 2020 with early adoption permitted. The Company is in the initial stage of evaluating the impact of this new standard on its notes and trade receivables.

10

Note 2. Real Estate Investments

At March 31, 2018, the Company had investments of approximately $413.3 million in 89 real estate properties, including one mortgage note. The following table summarizes the Company's real estate investments.

(Dollars in thousands)	Number of Facilities	Land and Land Improvements		Buildings, Improvements, and Lease Intangibles		Personal Property		Total		Accumulated Depreciation
Medical office buildings:
Florida	5	$	4,608	$	29,241	$	—	$	33,849	$	2,896
Ohio	5	3,167		23,527		—		26,694		3,951
Texas	3	3,096		13,898		—		16,994		3,579
Illinois	2	1,134		11,823		—		12,957		1,803
Kansas	2	1,427		10,497		—		11,924		2,541
Iowa	1	2,241		9,004		—		11,245		1,412
Other states	14	3,642		27,365		—		31,007		2,898
	32	19,315		125,355		—		144,670		19,080
Physician clinics:
Kansas	3	1,638		10,909		—		12,547		2,157
Illinois	2	2,615		6,354		—		8,969		151
Florida	4	253		9,484		—		9,737		568
Other states	9	3,194		18,472		—		21,666		3,316
	18	7,700		45,219		—		52,919		6,192
Surgical centers and hospitals:
Louisiana	1	1,683		21,353		—		23,036		711
Indiana	1	523		14,405		—		14,928		532
Michigan	2	628		8,272		—		8,900		2,057
Illinois	1	2,183		5,410		—		7,593		847
Florida	1	271		7,017		—		7,288		347
Arizona	2	576		5,389		—		5,965		1,127
Other states	5	1,555		11,000		—		12,555		3,046
	13	7,419		72,846		—		80,265		8,667
Specialty centers:
Illinois	3	3,482		24,717		—		28,199		519
Other states	16	2,609		29,913		—		32,522		4,930
	19	6,091		54,630		—		60,721		5,449
Behavioral facilities:
West Virginia	1	2,138		22,897		—		25,035		298
Illinois	1	1,300		18,803		—		20,103		862
Indiana	2	1,126		6,040		—		7,166		195
Other states	2	977		8,729		—		9,706		159
	6	5,541		56,469		—		62,010		1,514
Corporate property	—	—		2,011		116		2,127		150
Total owned properties	88	$	46,066	$	356,530	$	116	$	402,712	$	41,052
Mortgage note receivable	1	—		—		—		10,633		—
Total real estate investments	89	$	46,066	$	356,530	$	116	$	413,345	$	41,052

11

Notes to Condensed Consolidated Financial Statements - Continued

Note 3. Real Estate Leases

The Company’s properties are generally leased pursuant to non-cancelable, fixed-term operating leases with expiration dates through 2034. The Company’s leases generally require the lessee to pay minimum rent, with fixed rent renewal terms or increases based on a Consumer Price Index and and may also include additional rent, which may include taxes (including property taxes), insurance, maintenance and other operating costs associated with the leased property.

Future minimum lease payments under the non-cancelable operating leases due the Company for the years ending December 31, as of March 31, 2018, are as follows (in thousands):

2018 (nine months ending December 31)	$	27,856
2019	34,317
2020	31,425
2021	28,128
2022	24,973
2023 and thereafter	147,484
	$	294,183

Straight-line rental income

Rental income is recognized as earned over the life of the lease agreement on a straight-line basis. Straight-line rent included in rental income was approximately $0.4 million and $0.3 million, respectively, for the three months ended March 31, 2018 and 2017.

Deferred revenue

Rent received but not yet earned is deferred until such time it is earned. Deferred revenue, included in other liabilities, was approximately $1.3 million and $1.1 million, respectively, at March 31, 2018 and December 31, 2017.

Note 4. Real Estate Acquisitions

Property Acquisitions

During the first quarter of 2018, the Company acquired three real estate properties totaling approximately 38,000 square feet for an aggregate purchase price and cash consideration of approximately $12.7 million. Upon acquisition, the properties were 100% leased in the aggregate with lease expirations ranging from 2018 through 2033. Amounts reflected in revenues and net income for the three months ended March 31, 2018 for these properties was approximately $20,230 and $13,415, respectively. Transaction costs totaling approximately $101,000 related to these acquisitions were capitalized in the period and included, as applicable, in real estate assets or other assets.

Note 5. Mortgage Note Receivable

The Company had one mortgage note receivable outstanding as of March 31, 2018 and December 31, 2017 with a principal balance of $10.6 million and an interest receivable of $0.6 million. The borrower and several related entities (the "Borrower") filed for voluntary bankruptcy on June 23, 2017. At the time of filing for bankruptcy, the Borrower was current on all obligations to the Company, but no payments were received during the bankruptcy.

On December 28, 2017 the Company purchased $11.45 million face value of certain promissory notes, secured by accounts receivable of the Borrower, for $8.75 million from a syndicate of banks, a $2.7 million discount to face value, and in the first quarter of 2018 acquired $2.2 million of certain promissory notes, secured by the operations of two facilities related to the Borrower, but were not included in the bankruptcy, for a total investment in these promissory notes of approximately $10.95 million.

12

Notes to Condensed Consolidated Financial Statements - Continued

On April 25, 2018, the Company provided a new $23.0 million loan to a newly formed company (Newco), secured by all assets and ownership interests in seven long-term acute care hospitals and one inpatient rehabilitation hospital that, along with a series of investments by the management of Newco, allowed Newco to acquire certain assets of the Borrower.

Also on April 25, 2018, $10.95 million for the promissory notes discussed above and approximately $0.261 million of interest on those promissory notes and approximately $0.25 million in fees and reimbursement of expenses and approximately $6.7 million principal and accrued interest related to its mortgage note receivable were satisfied with proceeds from the new loan. In addition, the Company received title to the property previously financed by the mortgage note receivable at an approximate $4.5 million valuation, and the Company did not record interest on the mortgage note receivable during the first quarter of 2018. The Company does not believe that a material impairment exists, if any, at March 31, 2018, and therefore, has not recorded any impairment related to the bankruptcy.

Note 6. Debt, net

The table below details the Company's debt as of March 31, 2018 and December 31, 2017.

	Balance as of
(Dollars in thousands)	March 31, 2018		December 31, 2017		Maturity Dates
Revolving Credit Facility	$	12,000	$	34,000	8/19
5-Year Term Loan, net	49,703		29,685		3/22
7-Year Term Loan, net	49,682		29,668		3/24
	$	111,385	$	93,353

The Company's second amended and restated credit facility (the "Credit Facility") is by and among Community Healthcare OP, LP, the Company, the lenders from time to time party thereto, and SunTrust Bank, as Administrative Agent. The Company’s material subsidiaries are guarantors of the obligations under the Credit Facility. The Credit Facility provides for a $150.0 million revolving credit facility (the "Revolving Credit Facility") and $100.0 million in term loans (the "Term Loans"). The Credit Facility, through the accordion feature, allows borrowings up to a total of $450.0 million, including the ability to add and fund additional term loans. The Revolving Credit Facility matures on August 9, 2019 and includes two 12-month options to extend the maturity date of the Revolving Credit Facility, subject to the satisfaction of certain conditions. The Term Loans include a five-year term loan facility in the aggregate principal amount of $50.0 million (the "5-Year Term Loan") which matures on March 29, 2022 and a seven-year term loan facility in the aggregate principal amount of $50.0 million (the "7-Year Term Loan") which matures on March 29, 2024.

During the first quarter of 2018, the Company entered into two amendments relating to its Credit Facility. The first amendment, which was effective as of November 1, 2017, modified the formula used to calculate the amount of restricted payments the Company may make under the Credit Facility. The second amendment, effective on March 27, 2018, reduced the pricing margins on its LIBOR borrowings on both its Revolving Credit Facility and Term Loans and increased the maximum swingline commitment from $15.0 million to $20.0 million. The Company paid $0.2 million in fees related to these amendments.

Amounts outstanding under the Revolving Credit Facility, as amended, bear annual interest at a floating rate that is based, at the Company’s option, on either: (i) LIBOR plus 1.75% to 2.50% or (ii) a base rate plus 0.75% to 1.50%, in each case, depending upon the Company’s leverage ratio. In addition, the Company is obligated to pay an annual fee equal to 0.25% of the amount of the unused portion of the Revolving Credit Facility if amounts borrowed are greater than 33.3% of the borrowing capacity under the Revolving Credit Facility and 0.35% of the unused portion of the Revolving Credit Facility if amounts borrowed are less than or equal to 33.3% of the borrowing capacity

13

Notes to Condensed Consolidated Financial Statements - Continued

under the Revolving Credit Facility. At March 31, 2018, the Company had $12.0 million outstanding under the Revolving Credit Facility with a remaining borrowing capacity of $138.0 million.

Amounts outstanding under the Term Loans, as amended, bear annual interest at a floating rate that is based, at the Company’s option, on either: (i) LIBOR plus 1.95% to 2.65% or (ii) a base rate plus 0.95% to 1.65%, in each case, depending upon the Company’s leverage ratio. In addition, the Company is obligated to pay an annual fee equal to 0.35% of the amount of the unused portion of the Term Loans. The Company entered into interest rate swaps to fix the interest rates on the original Term Loan amounts drawn in 2017. On March 29, 2018, the Company borrowed the remaining $40.0 million, in equal amounts, available under its 5-Year and 7-Year Term Loans, repaid $40.0 million of its Revolving Credit Facility, and concurrently entered into interest rate swap agreements that fixed the interest rates on the additional $40.0 million drawn, resulting in fixed interest rates under the term loans ranging from 4.5790% to 4.6255%. See Note 7 for more details on the interest rate swaps. At March 31, 2018, the Company had drawn the full $100.0 million under the Term Loans which had a fixed weighted average interest rate under the swaps of approximately 4.45%.

The Company’s ability to borrow under the Credit Facility is subject to its ongoing compliance with a number of customary affirmative and negative covenants, including limitations with respect to liens, indebtedness, distributions, mergers, consolidations, investments, restricted payments and asset sales, as well as financial maintenance covenants. Also, the Company’s present financing policy prohibits incurring debt (secured or unsecured) in excess of 40% of its total book capitalization. The Company was in compliance with its financial covenants under its Credit Facility as of March 31, 2018.

Note 7. Derivative Financial Instruments

Risk Management Objective of Using Derivatives

The Company may use derivative financial instruments, including interest rate swaps, caps, options, floors and other interest rate derivative contracts, to hedge all or a portion of the interest rate risk associated with its borrowings. The principal objective of such arrangements is to minimize the risks and/or costs associated with the Company’s operating and financial structure as well as to hedge specific anticipated transactions. The Company does not intend to utilize derivatives for speculative or other purposes other than interest rate risk management. The use of derivative financial instruments carries certain risks, including the risk that the counterparties to these contractual arrangements are not able to perform under the agreements. To mitigate this risk, the Company only enters into derivative financial instruments with counterparties with high credit ratings and with major financial institutions with which the Company and its affiliates may also have other financial relationships. The Company does not anticipate that any of the counterparties will fail to meet their obligations.

Cash Flow Hedges of Interest Rate Risk

The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps and/or caps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable-rate amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. Interest rate caps designated as cash flow hedges involve the receipt of variable-rate amounts if interest rates rise above the cap strike rate on the contract.

14

Notes to Condensed Consolidated Financial Statements - Continued

As of March 31, 2018, the Company had four outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk for notional amounts totaling $100.0 million. The table below presents the fair value of the Company’s derivative financial instruments as well as their classification on the Condensed Consolidated Balance Sheets as of March 31, 2018 and December 31, 2017.

	Asset Derivatives Fair Value at					Liability Derivatives Fair Value at
	March 31, 2018		December 31, 2017		Balance Sheet Classification	March 31, 2018		December 31, 2017		Balance Sheet Classification
Interest rate swaps	$	1,352	$	258	Other assets	$	119	$	—	Other Liabilities

The changes in the fair value of derivatives designated and that qualify as cash flow hedges are recorded in accumulated other comprehensive income and is subsequently reclassified to interest expense in the period that the hedged forecasted transaction affects earnings.

Amounts reported in accumulated other comprehensive income related to derivatives will be reclassified to interest expense as interest payments are made on the Company’s Term Loans. During the next twelve months, the Company estimates that an additional $0.1 million will be reclassified from other comprehensive income ("OCI") as an increase to interest expense.

The table below details the location in the financial statements of the gain or loss recognized on interest rate derivatives designated as cash flow hedges for the three months ended March 31, 2018.

(Dollars in thousands)	Three Months Ended March 31, 2018		Three Months Ended March 31, 2017
Amount of unrealized gain (loss) recognized in OCI on derivative	$	906	$	(158	)
Amount of loss reclassified from accumulated OCI into interest expense	$	68	$	6
Total Interest Expense presented in the Condensed Consolidated Statements of Income in which the effects of the cash flow hedges are recorded	$	1,268	$	597

Credit-risk-related Contingent Features

As of March 31, 2018, the fair value of derivatives in a net liability position including accrued interest but excluding any adjustment for nonperformance risk related to these agreements was $0.1 million. As of March 31, 2018, the Company has not posted any collateral related to these agreements and was not in breach of any agreement provisions. If the Company had breached any of these provisions, it could have been required to settle its obligations under the agreements at their aggregate termination value of approximately $0.1 million at March 31, 2018.

Note 8. Stockholders’ Equity

Common Stock

The following table provides a reconciliation of the beginning and ending common stock balances for the three months ended March 31, 2018 and for the year ended December 31, 2017:

	Three Months Ended March 31, 2018	Year Ended December 31, 2017
Balance, beginning of period	18,085,798	12,988,482
Issuance of common stock	—	4,887,500
Restricted stock-based awards	94,001	209,816
Balance, end of period	18,179,799	18,085,798

15

Notes to Condensed Consolidated Financial Statements - Continued

Equity Offering

On July 26, 2017, the Company completed a public offering of 4,887,500 shares of its common stock, including 637,500 shares of common stock issued in connection with the exercise in full of the underwriters' option to purchase additional shares, and received net proceeds of approximately $108.6 million after deducting underwriting discount and commissions and offering expenses paid by the Company. Proceeds from the offering were used to repay the outstanding balance on our revolving credit facility totaling $58.0 million and for additional investments during 2017.

Note 9. Net Income Per Common Share

The following table sets forth the computation of basic and diluted net income per common share.

	Three Months Ended March 31, 2018
(Dollars in thousands, except per share data)	2018			2017
Net income	$	1,872		$	913
Participating securities' share in earnings	(241		)	—
Net income, less participating securities' share in earnings	$	1,631		$	913
Weighted average Common Shares outstanding
Weighted average Common Shares outstanding	18,164,132			13,089,684
Unvested restricted stock	(590,449		)	(403,501		)
Weighted average Common Shares outstanding–Basic	17,573,683			12,686,183
Weighted average Common Shares outstanding–Basic	17,573,683			12,686,183
Dilutive potential common shares	—			133,313
Weighted average Common Shares outstanding –Diluted	17,573,683			12,819,496
Basic Net Income per Common Share	$	0.09		$	0.07
Diluted Net Income per Common Share	$	0.09		$	0.07

Note 10. Incentive Plan

Under the Company's 2014 Incentive Plan, awards may be made in the form of restricted stock, cash or a combination of both. Compensation expense recognized from the amortization of the value of the Company's officer, employee and director shares over the applicable vesting periods during the three months ended March 31, 2018 and 2017 was approximately $0.6 million and $0.3 million, respectively.

A summary of the activity under the 2014 Incentive Plan for the three months ended March 31, 2018 and 2017 is included in the table below.

		Three Months Ended March 31,
		2018	2017
Stock-based awards, beginning of period		512,115	302,299
	Stock in lieu of compensation	47,027	59,285
	Stock awards	46,974	57,486
	Total stock granted	94,001	116,771
Stock-based awards, end of period		606,116	419,070

16

Note 11. Other Assets

Other assets consists primarily of notes receivable, accounts and interest receivables, straight-line rent receivables, fair value of interest rate swaps, prepaid assets and deferred financing costs. Items included in "Other assets, net" on the Company's Condensed Consolidated Balance Sheets as of March 31, 2018 and December 31, 2017 are detailed in the table below.

	Balance as of
(Dollars in thousands)	March 31, 2018			December 31, 2017
Notes receivable	$	16,018		$	13,917
Accounts and interest receivables	3,220			2,417
Straight-line rent receivables	2,457			2,179
Allowance for doubtful accounts	(191		)	(293		)
Prepaid assets	294			341
Deferred financing costs, net	721			618
Leasing commissions, net	455			483
Deferred tax asset	610			478
Fair value of interest rate swaps	1,352			258
Other	274			255
	$	25,210		$	20,653

The Company's $16.0 million in notes receivable at March 31, 2018 include mainly the following notes. Interest related to these notes is included in Other Operating Income on the Company's Condensed Consolidated Income Statements.

• During 2017, concurrent with the acquisition of a property, the Company entered into a $5.0 million note receivable with the tenant in the building. The $5.0 million note receivable, which matures on September 27, 2022, currently bears interest at 12% per annum, increasing through the maturity date to 16% per annum, and payments aggregating approximately $1.9 million are due each year until maturity with the remaining amount due at maturity.

• On December 27, 2017, the Company purchased, at a $2.7 million discount to face value, certain promissory notes for $8.75 million which were held by a syndicate of banks that were also creditors of our Borrower. See Note 5 for more details.

• During the first quarter of 2018, the Company acquired $2.2 million of certain promissory notes, secured by the operations of two facilities of our Borrower, which were not included in the bankruptcy. See Note 5 for more details.

17

The Company identified the borrowers of these notes as VIEs, but management determined that the Company was not the primary beneficiary of the VIEs because we lack either directly or through related parties any material impact in the activities that impact the borrowers' economic performance. We are not obligated to provide support beyond our stated commitment to the borrowers, and accordingly our maximum exposure to loss as a result of this relationship is limited to the amount of our outstanding notes receivable as noted above. The VIEs that we have identified at March 31, 2018 are summarized in the table below.

Classification	Carrying Amount (in millions)		Maximum Exposure to Loss (in millions)
Notes receivable	$	5.0	$	5.0
Notes receivable	$	8.8	$	8.8
Notes receivable	$	1.5	$	1.5
Notes receivable	$	0.7	$	0.7

Note 12. Fair Value of Financial Instruments

The following methods and assumptions were used to estimate the fair value of each class of financial instruments for which it is practical to estimate the fair value.

Cash and cash equivalents - The carrying amount approximates the fair value.

Mortgage note receivable - The fair value is estimated using cash flow analyses, based on an assumed market rate of interest or at a rate consistent with the rates on mortgage notes acquired by the Company and are classified as level 2 in the hierarchy.

Notes receivable - The fair value is estimated using cash flow analyses, based on an assumed market rate of interest or at a rate consistent with the rates on notes carried by the Company and are classified as level 2 in the hierarchy.

Borrowings under our Credit Facility - The carrying amount approximates the fair value because the borrowings are based on variable market interest rates.

Interest rate swaps - The fair value is estimated using discounted cash flow techniques. These techniques incorporate primarily level 2 inputs. The market inputs are utilized in the discounted cash flow calculation considering the instrument’s term, notional amount, discount rate and credit risk. Significant inputs to the derivative valuation model for interest rate swaps are observable in active markets and are classified as level 2 in the hierarchy.

The table below details the fair values and carrying values for our mortgage note and notes receivable and interest rate swaps at March 31, 2018 and December 31, 2017, using level 2 inputs.

	March 31, 2018				December 31, 2017
(Dollars in thousands)	Carrying Value		Fair Value		Carrying Value		Fair Value
Mortgage note receivable	$	10,633	$	10,633	$	10,633	$	10,633
Notes receivable	$	16,018	$	16,029	$	13,917	$	13,828
Interest rate swap asset	$	1,352	$	1,352	$	258	$	258
Interest rate swap liability	$	119	$	119	$	—	$	—

18

Notes to Condensed Consolidated Financial Statements - Continued

Note 13. Subsequent Events

Dividend Declared

On May 3, 2018, the Company’s Board of Directors declared a quarterly common stock dividend in the amount of $0.40 per share. The dividend is payable on June 1, 2018 to stockholders of record on May 18, 2018.

19

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Disclosure Regarding Forward-Looking Statements

This report and other materials that Community Healthcare Trust Incorporated (the "Company") has filed or may file with the Securities and Exchange Commission, as well as information included in oral statements or other written statements made, or to be made, by management of the Company, contain, or will contain, contains statements that are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are generally identifiable by use of forward-looking terminology such as “believes”, “expects”, “may”, “should”, “seeks”, “approximately”, “intends”, “plans”, “estimates”, “anticipates” or other similar words or expressions, including the negative thereof. Forward-looking statements are based on certain assumptions and can include future expectations, future plans and strategies, financial and operating projections or other forward-looking information. Such forward-looking statements reflect management’s current beliefs and are based on information currently available to management. Because forward-looking statements relate to future events, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of the Company’s control. Thus, the Company’s actual results and financial condition may differ materially from those indicated in such forward-looking statements. Some factors that might cause such a difference include the following: general volatility of the capital markets and the market price of the Company’s common stock, changes in the Company’s business strategy, availability, terms and deployment of capital, the Company’s ability to refinance existing indebtedness at or prior to maturity on favorable terms, or at all, changes in the real estate industry in general, interest rates or the general economy, adverse developments related to the healthcare industry, the degree and nature of the Company’s competition, the ability to consummate acquisitions under contract and the other factors described in the section entitled “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017, and the Company’s other filings with the Securities and Exchange Commission from time to time. Readers are therefore cautioned not to place undue reliance on the forward-looking statements contained herein which speak only as of the date hereof. The Company intends these forward-looking statements to speak only as of the time of this report and the Company undertakes no obligation to update forward-looking statements, whether as a result of new information, future developments, or otherwise, except as may be required by law.

The purpose of this Management's Discussion and Analysis ("MD&A") is to provide an understanding of the Company's consolidated financial condition, results of operations and cash. MD&A is provided as a supplement to, and should be read in conjunction with, the Company's Condensed Consolidated Financial Statements and accompanying notes.

Overview

References such as "we," "us," "our," and "the Company" mean Community Healthcare Trust Incorporated, a Maryland corporation, and its consolidated subsidiaries, including Community Healthcare OP, LP, a Delaware limited partnership of which we are the sole general partner (the "OP").

We were organized in the State of Maryland on March 28, 2014. We are a self-administered, self-managed healthcare real estate investment trust, or REIT, that acquires and owns properties that are leased to hospitals, doctors, healthcare systems or other healthcare service providers in our target submarkets. The Company conducts its business through an UPREIT structure in which its properties are owned by the OP, either directly or through subsidiaries. The Company is the sole general partner, owning 100% of the OP units.

Trends and Matters Impacting Operating Results

Management monitors factors and trends that it believes are important to the Company and the REIT industry in order to gauge their potential impact on the operations of the Company. Certain of the factors and trends that management believes may impact the operations of the Company are discussed below.

20

Real estate acquisitions

During the first quarter of 2018, the Company acquired three real estate properties totaling approximately 38,000 square feet for an aggregate purchase price and cash consideration of approximately $12.7 million. Upon acquisition, the properties were 100% leased in the aggregate with lease expirations ranging from 2018 through 2033. See Note 4 to the Condensed Consolidated Financial Statements for more details on these acquisitions.

Acquisition Pipeline

The Company has two properties under definitive purchase agreements for an aggregate expected purchase price of approximately $7.3 million. The Company's expected return on these investments range from approximately 9.0% to 9.3%. The Company anticipates these properties will close during the second quarter of 2018. However, the Company is currently performing due diligence procedures customary for these types of transactions and cannot provide assurance as to the timing of when, or whether, these transactions will actually close.

The Company also has four properties under definitive purchase agreements, to be acquired after completion and occupancy, for an aggregate expected purchase price of approximately $76.0 million. The Company's expected aggregate return on these investments in approximately 11.0%. The Company expects to close these properties through the end of 2019; however, the Company cannot provide assurance as to the timing of when, or whether, these transactions will actually close.

The Company anticipates funding these investments with cash from operations, through proceeds from its Credit Facility or from net proceeds from additional debt or equity offerings.

Leased square footage

As of March 31, 2018, our real estate portfolio was approximately 91.2% leased. During the first quarter of 2018, we had expiring or terminated leases related to approximately 21,000 square feet and leased or renewed leases relating to approximately 98,000 square feet.

Off-Balance Sheet Arrangements

We have no off-balance sheet arrangements that are reasonably likely to have a material effect on the Company's consolidated financial condition, results of operations or liquidity.

Inflation

We believe inflation will have a minimal impact on the operating performance of our properties. Many of our lease agreements contain provisions designed to mitigate the adverse impact of inflation. These provisions include clauses that enable us to receive payment of increased rent pursuant to escalation clauses which generally increase rental rates during the terms of the leases. These escalation clauses often provide for fixed rent increases or indexed escalations (based upon the Consumer Price Index or other measures). However, some of these contractual rent increases may be less than the actual rate of inflation. Generally, our lease agreements require the tenant to pay property operating expenses, including maintenance costs, real estate taxes and insurance. This requirement reduces our exposure to increases in these costs and property operating expenses resulting from inflation.

Seasonality

We do not expect our business to be subject to material seasonal fluctuations.

New Accounting Pronouncements

See Note 1 to the Company’s Condensed Consolidated Financial Statements accompanying this report for information on new accounting standards not yet adopted.

21

Results of Operations

The Company's results of operations for the three months ended March 31, 2018 compared to the same period in 2017 have most significantly been impacted by its real estate acquisitions. As of March 31, 2018 and 2017, the Company had investments in real estate properties, including a mortgage note, totaling approximately $413.3 million and $293.2 million, respectively.

Three Months Ended March 31, 2018 Compared to Three Months Ended March 31, 2017

The table below shows our results of operations for the three months ended March 31, 2018 compared to the same period in 2017 and the effect of changes in those results from period to period on our net income.

	Three Months Ended March 31,						Increase (Decrease) to Net Income
(dollars in thousands)	2018			2017			$			%
REVENUES
Rental income	$	9,635		$	6,618		$	3,017		45.6	%
Tenant reimbursements	1,440			1,128			312			27.7	%
Mortgage interest	—			261			(261		)	(100.0	)%
Other operating	354			—			354			n/m
	11,429			8,007			3,422			42.7	%
EXPENSES
Property operating	2,364			1,738			(626		)	(36.0	)%
General and administrative	1,193			770			(423		)	(54.9	)%
Depreciation and amortization	4,916			3,924			(992		)	(25.3	)%
Bad debts	—			67			67			100.0	%
	8,473			6,499			(1,974		)	(30.4	)%
OTHER INCOME (EXPENSE)
Interest expense	(1,268		)	(597		)	(671		)	(112.4	)%
Interest and other income, net	184			2			182			9,100.0	%
	(1,084		)	(595		)	(489		)	(82.2	)%
NET INCOME	$	1,872		$	913		$	959		105.0	%

__________

n/m-not meaningful.

22

Revenues

Revenues increased approximately $3.4 million, or 42.7%, for the three months ended March 31, 2018 compared to the same period in 2017 due mainly to our acquisitions which contributed an increase in revenues of approximately $3.6 million.

Expenses

Property operating expenses increased approximately $0.6 million, or 36.0%, for the three months ended March 31, 2018 compared to the same period in 2017 mainly due to the following:

• Acquisitions accounted for an increase of approximately $0.3 million; and

• Increases in utilities, property taxes and other property expenses related to our properties prior to 2017 of approximately $0.3 million.

General and administrative expenses increased approximately $0.4 million, or 54.9%, for the three months ended March 31, 2018 compared to the same period in 2017 due mainly to compensation-related expenses and occupancy costs related to our employees and corporate office, including the amortization of non-vested restricted common shares issued under the 2014 Incentive Plan and expenses related to the addition of employees.

Depreciation and amortization expense increased approximately $1.0 million, or 25.3%, for the three months ended March 31, 2018 compared to the same period in 2017 due mainly to the following:

• Depreciation and amortization related to property acquisitions accounted for an increase of approximately $1.5 million; and

• Real estate intangible assets that fully depreciated resulted in a decrease of approximately $0.5 million.

Interest expense

Interest expense increased approximately $0.7 millionfor the three months ended March 31, 2018 compared to the same period in 2017 due mainly to the Company's borrowings under its Term Loans under the Company's Credit Facility in the first quarters of 2017 and 2018. The Company borrowed $60.0 million in Term Loans and borrowed the remaining $40.0 million in Term Loans in the first quarter of 2018 which are at higher interest rates than the Revolving Credit Facility repaid with the Term Loan proceeds. The Company's weighted average debt balance was also higher in the first quarter of 2018 compared to the same period in 2017.

Funds from Operations

Funds from operations (“FFO”) and FFO per share are operating performance measures adopted by the National Association of Real Estate Investment Trusts, Inc. (“NAREIT”). NAREIT defines FFO as the most commonly accepted and reported measure of a REIT’s operating performance equal to “net income (computed in accordance with GAAP), excluding gains (or losses) from sales of property, plus depreciation and amortization related to real estate properties, and after adjustments for unconsolidated partnerships and joint ventures.”

Management believes that net income, as defined by GAAP, is the most appropriate earnings measurement. However, management believes FFO and FFO per share to be supplemental measures of a REIT’s performance because they provide an understanding of the operating performance of the Company’s properties without giving effect to certain significant non-cash items, primarily depreciation and amortization expense. Historical cost accounting for real estate assets in accordance with GAAP assumes that the value of real estate assets diminishes predictably over time. However, real estate values instead have historically risen or fallen with market conditions. The Company believes that by excluding the effect of depreciation, amortization and gains or losses from sales of

23

real estate, all of which are based on historical costs and which may be of limited relevance in evaluating current performance, FFO and FFO per share can facilitate comparisons of operating performance between periods. The Company reports FFO and FFO per share because these measures are observed by management to also be the predominant measures used by the REIT industry and by industry analysts to evaluate REITs and because FFO per share is consistently reported, discussed, and compared by research analysts in their notes and publications about REITs. For these reasons, management has deemed it appropriate to disclose and discuss FFO and FFO per share. However, FFO does not represent cash generated from operating activities determined in accordance with GAAP and is not necessarily indicative of cash available to fund cash needs. FFO should not be considered as an alternative to net income attributable to common stockholders as an indicator of the Company’s operating performance or as an alternative to cash flow from operating activities as a measure of liquidity. The table below reconciles FFO to net income for the three months ended March 31, 2018 and 2017, respectively.

	Three Months Ended March 31,
(Dollars in thousands, excepts per share amounts)	2018		2017
Net income	$	1,872	$	913
Real estate depreciation and amortization	4,911		3,921
Total adjustments	4,911		3,921
Funds from Operations	$	6,783	$	4,834
Funds from Operations per Common Share-Basic	$	0.39	$	0.38
Funds from Operations per Common Share-Diluted	$	0.38	$	0.38
Weighted Average Common Shares Outstanding-Basic	17,573,683		12,686,183
Weighted Average Common Shares Outstanding-Diluted (1)	17,791,436		12,819,496

(1) Diluted weighted average common shares outstanding for FFO are calculated based on the treasury method, rather than the 2-class method used to calculate earnings per share.

Liquidity and Capital Resources

The Company monitors its liquidity and capital resources and relies on several key indicators in its assessment of capital markets for financing acquisitions and other operating activities as needed, including the following:

• Leverage ratios and financial covenants included in our Credit Facility;

• Dividend payout percentage; and

• Interest rates, underlying treasury rates, debt market spreads and equity markets.

The Company uses these indicators and others to compare its operations to its peers and to help identify areas in which the Company may need to focus its attention.

Sources and Uses of Cash

The Company derives most of its revenues from its real estate property and mortgage note portfolio, collecting rental income, operating expense reimbursements and mortgage interest based on contractual arrangements with its tenants and borrowers. These sources of revenue represent our primary source of liquidity to fund our dividends, general and administrative expenses, property operating expenses, interest expense on our Credit Facility and other expenses incurred related to managing our existing portfolio and investing in additional properties. To the extent additional resources are needed, the Company will fund its investment activity generally through equity or debt issuances either in the public or private markets or through proceeds from our Credit Facility.

24

The Company expects to meet its liquidity needs through cash on hand, cash flows from operations and cash flows from sources discussed above. The Company believes that its liquidity and sources of capital are adequate to satisfy its cash requirements. The Company cannot, however, be certain that these sources of funds will be available at a time and upon terms acceptable to the Company in sufficient amounts to meet its liquidity needs.

The Company's Credit Facility provides for a $150.0 million Revolving Credit Facility and $100.0 million in Term Loans, as well as an accordion feature which allows borrowings up to a total of $450.0 million, including the ability to add and fund additional term loans. Note 6 to the Condensed Consolidated Financial Statements provides more details on the Company's Credit Facility. At March 31, 2018, the Company had borrowed $100.0 million in Term Loans and had $12.0 million outstanding under the Revolving Credit Facility with a remaining borrowing capacity of $138.0 million. At March 31, 2018, our debt to total book capitalization ratio was approximately 28.5%.

Acquisition Pipeline

The Company has two properties under definitive purchase agreements for an aggregate expected purchase price of approximately $7.3 million. The Company's expected return on these investments range from approximately 9.0% to 9.3%. The Company anticipates these properties will close during the second quarter of 2018. However, the Company is currently performing due diligence procedures customary for these types of transactions and cannot provide assurance as to the timing of when, or whether, these transactions will actually close.

The Company also has four properties under definitive purchase agreements, to be acquired after completion and occupancy, for an aggregate expected purchase price of approximately $76.0 million. The Company's expected aggregate return on these investments in approximately 11.0%. The Company expects to close these properties through the end of 2019; however, the Company cannot provide assurance as to the timing of when, or whether, these transactions will actually close.

The Company anticipates funding these investments with cash from operations, through proceeds from its Credit Facility or from net proceeds from additional debt or equity offerings.

Universal Shelf S-3 Registration Statement

The Company has approximately $635.4 million remaining to be issued under its Form S-3 registration statement filed on September 13, 2016 with the Securities and Exchange Commission, and declared effective on September 26, 2016. The registration statement allows us to offer debt or equity securities (or a combination thereof) from time to time.

Operating Activities

Cash flows provided by operating activities for the three months ended March 31, 2018 and 2017 were approximately $5.9 million and $4.6 million, respectively. Cash flows provided by operating activities were generally provided by contractual rents, net of expenses, on our real estate property portfolio.

Investing Activities

Cash flows used in investing activities for the three months ended March 31, 2018 and 2017 were approximately $16.3 million and $29.2 million, respectively. During the three months ended March 31, 2018, the Company invested in three properties for an aggregate purchase price and cash consideration of approximately $12.7 million. In addition, the Company acquired $2.2 million of certain promissory notes secured by two facilities related to its Borrower, discussed in more detail in Note 5 to the Condensed Consolidated Financial Statements. During the three months ended March 31, 2017, the Company invested in 10 properties for an aggregate purchase price of approximately $28.5 million, including approximately $28.4 million in cash consideration. During the first quarter of 2017, the Company also acquired a property, adjacent to its corporate office, for a cash purchase price of approximately $0.9 million. The property is currently leased to a tenant but the Company intends to use the property for future expansion of its corporate office.

25

Financing Activities

Cash flows provided by financing activities for the three months ended March 31, 2018 and 2017 were approximately $10.6 million and $25.2 million, respectively. During the three months ended March 31, 2018, the Company borrowed the remaining $40.0 million under its Term Loans, which was used to repay outstanding amounts on its Revolving Credit Facility, and paid a quarterly dividend. During the three months ended March 31, 2017, the Company amended its Credit Facility, borrowing $60.0 million in Term Loans, repaid $29.0 million of its Revolving Credit Facility with proceeds from the Term Loans and paid a quarterly dividend.

Security Deposits

As of March 31, 2018, the Company held approximately $2.5 million in security deposits for the benefit of the Company in the event the obligated tenant fails to perform under the terms of its respective lease. Generally, the Company may, at its discretion and upon notification to the tenant, draw upon the security deposits if there are any defaults under the leases.

Dividends

The Company is required to pay dividends to its stockholders at least equal to 90% of its taxable income in order to maintain its qualification as a REIT.

On May 3, 2018, the Company’s Board of Directors declared a quarterly common stock dividend in the amount of $0.40 per share. The dividend is payable on June 1, 2018 to stockholders of record on May 18, 2018. This rate equates to an annualized dividend of $1.60 per share.

On March 2, 2018, the Company paid a cash dividend in the amount of $0.3975 per share to shareholders of record on February 16, 2018.

The ability of the Company to pay dividends is dependent upon its ability to generate cash flows and to make accretive new investments.

26

ITEM 3. Quantitative and Qualitative Disclosures about Market Risk

Our future income, cash flows and fair values relevant to financial instruments are dependent upon prevailing market interest rates. Market risk refers to the risk of loss from adverse changes in market prices and interest rates. We may use certain derivative financial instruments to manage, or hedge, interest rate risks related to our borrowings. We will not use derivatives for trading or speculative purposes and only enter into contracts with major financial institutions based upon their credit rating and other factors. An interest rate swap is a contractual agreement entered into by two counterparties under which each agrees to make periodic payments to the other for an agreed period of time based on a notional amount of principal. Under the most common form of interest rate swap, known from our perspective as a floating-to-fixed interest rate swap, a series of floating, or variable, rate payments on a notional amount of principal is exchanged for a series of fixed interest rate payments on such notional amount.

ITEM 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rules 13a-15(b) and 15d-15(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), as of the end of the period covered by this report. Based on this evaluation, Company’s management has concluded that, as of the end of such period, the Company’s disclosure controls and procedures were effective in recording, processing, summarizing and reporting, on a timely basis, information required to be disclosed by the Company in the reports it files or submits under the Exchange Act.

Changes In Internal Control Over Financial Reporting

There were no changes in our system of internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended March 31, 2018 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

ITEM 1.    LEGAL PROCEEDINGS

The Company may, from time to time, be involved in litigation arising in the ordinary course of business or which may be expected to be covered by insurance. The Company is not aware of any pending or threatened litigation that, if resolved against the Company, would have a material adverse effect on the Company’s consolidated financial position, results of operations or cash flows.

ITEM 1A.    RISK FACTORS

In addition to the other information set forth in this quarterly report, an investor should consider the risk factors included in its Annual Report on Form 10-K for the year ended December 31, 2017, and other reports that may be filed by the Company.

ITEM 2.   UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

27

ITEM 3.   DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4.   MINE SAFETY DISCLOSURES

None.

ITEM 5.   OTHER INFORMATION

Item 1.01.    Entry into a Material Definitive Agreement

On February 15, 2018, the Company entered into the first amendment (the "First Amendment") to its Second Amended and Restated Credit Agreement (the "Credit Facility") with a syndicate of lenders co-led by SunTrust Robinson Humphrey Inc., BB&T, and Fifth Third Bank. The First Amendment, which was effective as of November 1, 2017, modified the formula used to calculate the amount of restricted payments the Company may make under the Credit Facility.

The foregoing description is only a summary of certain provisions of the First Amendment and is qualified in its entirety by reference to the text of the First Amendment, which is filed as Exhibit 10.1 to this Quarterly Report on Form 10-Q.

ITEM 6.    EXHIBITS

The exhibits required by Item 601 of Regulation S-X which are filed with this report are listed in the Exhibit Index and are hereby incorporated in by reference.

28

EXHIBIT INDEX

Exhibit Number	Description
3.1	Corporate Charter of Community Healthcare Trust Incorporated, as amended (1)
3.2	Bylaws of Community Healthcare Trust Incorporated, as amended (2)
10.1 *	First Amendment to the Second Amended and Restated Credit Agreement
10.2	Second Amendment to Employment Agreement between Community Healthcare Trust Incorporated and Timothy G. Wallace (3)
10.3	Second Amendment to Employment Agreement between Community Healthcare Trust Incorporated and W. Page Barnes (4)
10.4	Second Amendment to Employment Agreement between Community Healthcare Trust Incorporated and Leigh Ann Stach (5)
31.1 *	Certification of the Chief Executive Officer of Community Healthcare Trust Incorporated pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Rule 302 of the Sarbanes-Oxley Act of 2002
31.2 *	Certification of the Chief Financial Officer of Community Healthcare Trust Incorporated pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Rule 302 of the Sarbanes-Oxley Act of 2002
32.1 **	Certifications pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
99.1 *	Second Amendment to the Second Amended and Restated Credit Agreement
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema Document
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document
101.LAB	XBRL Taxonomy Extension Labels Linkbase Document
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document

(1) Filed as Exhibit 3.1 to Amendment No. 2 to the Registration Statement on Form S-11 of the Company filed with the Securities and Exchange Commission on May 6, 2015 (Registration No. 333-203210)and incorporated herein by reference.

(2) Filed as Exhibit 3.2 to the Registration Statement on Form S-11 of the Company filed with the Securities and Exchange Commission on April 2, 2015 (Registration No. 333-203210)and incorporated herein by reference.

(3) Filed as Exhibit 10.1 to the Form 8-K of the Company filed with the Securities and Exchange Commission on January 2, 2018.

(4) Filed as Exhibit 10.2 to the Form 8-K of the Company filed with the Securities and Exchange Commission on January 2, 2018.

(5) Filed as Exhibit 10.3 to the Form 8-K of the Company filed with the Securities and Exchange Commission on January 2, 2018.

_________

* Filed herewith.

** Furnished herewith.

29

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: May 8, 2018

COMMUNITY HEALTHCARE TRUST INCORPORATED
By:	/s/ Timothy G. Wallace
	Timothy G. Wallace
	Chief Executive Officer and President
By:	/s/ W. Page Barnes
	W. Page Barnes
	Executive Vice President and Chief Financial Officer

30

EX-10.1

Exhibit 10.1

FIRST AMENDMENT TO SECOND AMENDED AND RESTATED CREDIT AGREEMENT

THIS FIRST AMENDMENT TO SECOND AMENDED AND RESTATED CREDIT AGREEMENT dated as of February 15, 2018 (the “Agreement”), is executed by each of the Lenders hereto, SUNTRUST BANK, as Agent (the “Agent”), COMMUNITY HEALTHCARE OP, LP, a Delaware limited partnership (the “Borrower”), COMMUNITY HEALTHCARE TRUST INCORPORATED, a Maryland corporation (the “REIT Guarantor”), the Subsidiary Loan Parties and the other parties hereto.

WHEREAS, the Borrower, the REIT Guarantor, the financial institutions signatory thereto and their assignees thereunder (the “Lenders”), the Agent, and the other parties thereto, have entered into that certain Second Amended and Restated Credit Agreement dated as of March 29, 2017 (as amended, restated, supplemented or otherwise modified from time to time, the “Credit Agreement”); and

WHEREAS, the Borrower and REIT Guarantor have requested to waive the Specified Events of Default (as defined in Section 2 below) and to make certain amendments to the Credit Agreement and as set forth herein and the Agent and the Lenders have agreed to such waiver and amendments on the terms and conditions set forth herein.

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which hereby are acknowledged by the parties hereto, the parties hereto hereby agree as follows:

Section 1. Specific Amendments to Credit Agreement. Subject to the satisfaction of the conditions precedent set forth in Section 3 below, the parties hereto agree that the Credit Agreement is amended, effective as of November 1, 2017, by restating Section 6.5. thereof in its entirety as follows:

Section 6.5.    Restricted Payments.

(a)    During each Fiscal Quarter ending (1) December 31, 2017, March 31, 2018 and June 30, 2018, the REIT Guarantor and the Borrower shall not, and shall not permit any of their respective Subsidiaries to, make any Restricted Payments during such period in excess of the greater of (i) $7,500,000 and (ii) the amount required for the REIT Guarantor to maintain its status as a REIT and (2) September 30, 2018 and December 31, 2018, the REIT Guarantor and the Borrower shall not, and shall not permit any of their respective Subsidiaries to, make any Restricted Payments during such period in excess of the greater of (i) $8,000,000 and (ii) the amount required for the REIT Guarantor to maintain its status as a REIT; and

(b)    On and at all times after January 1, 2019, the REIT Guarantor and the Borrower shall not, and shall not permit any of their respective Subsidiaries to, make any Restricted Payments during the Applicable Period most recently ended in excess of the greater of (i) 95.0% of Funds From Operations of the REIT Guarantor for such Applicable Period and (ii) the amount required for the REIT Guarantor to maintain its status as a REIT.

Notwithstanding the foregoing, (i) but subject to the following clause (ii), if a Default or Event of Default exists, the REIT Guarantor and the Borrower shall not, and shall not permit any of their respective Subsidiaries to, make any Restricted Payments in excess of the amount permitted pursuant to the foregoing clauses (a)(1)(ii), (a)(2)(ii) and (b)(ii) and (ii) if an Event of Default specified in Section 8.1(a), (b), (g), (h), or (i) shall exist, or if as a result of the occurrence of any other Event of Default any of the Obligations have been accelerated, the REIT Guarantor and the Borrower shall not, and shall not permit any Subsidiary to, make any Restricted Payments to any Person other than to the Borrower or any Subsidiary Loan Party.

Section 2. Limited Waiver. Subject to the satisfaction of the conditions precedent set forth in Section 3 below, the Lenders party hereto hereby waive, effective as of the date and time the Specified Events of Default are deemed to have occurred, any and all Events of Default arising under Section 8.1.(d) of the Credit Agreement by

virtue of (i) the Borrower and REIT Guarantor making Restricted Payments in excess of the amount permitted by Section 6.5.(c)(2) of the Credit Agreement (as in effect immediately prior to this Agreement) and (ii) any failure by the Borrower and REIT Guarantor to deliver notices to the Agent with respect to the foregoing under Section 5.2.(a)(i) of the Credit Agreement (collectively, the “Specified Events of Default”). The Borrower and REIT Guarantor acknowledge and agree that the waivers contained in this Section 2 shall not waive or amend (or be deemed to be or constitute an amendment to or waiver of) any other covenant, term or provision in the Credit Agreement or any other Loan Document or hinder, restrict or otherwise modify the rights and remedies of the Lenders and the Agent following the occurrence of any other present or future Default or Event of Default under the Credit Agreement or any other Loan Document.

Section 3. Conditions Precedent. The effectiveness of this Agreement is subject to receipt by the Agent of each of the following, each in form and substance reasonably satisfactory to the Agent:

(a)    a counterpart of this Agreement duly executed by the Borrower, the REIT Guarantor, the Agent and the Required Lenders;

(b)    a certificate signed by a Responsible Officer and the chief financial officer of the REIT Guarantor and the Borrower, certifying that, after giving effect to the transactions contemplated hereby, that (i) no Default or Event of Default shall be in existence on the date hereof and (ii) each representation and warranty made or deemed made by the Borrower or any other Loan Party in each Loan Document to which any such Loan Party is a party is true and correct in all material respects (or in the case of representations and warranties that are expressly qualified by a Material Adverse Effect or other materiality qualifier, in all respects) on the date hereof except to the extent that such representations and warranties expressly related solely to an earlier date (in which case such representations and warranties shall have been true and correct in all material respects (or in the case of representations and warranties that are expressly qualified by a Material Adverse Effect or other materiality qualifier, in all respects) on and as of such earlier date);

(c)    evidence that all fees then due and payable by the Borrower in connection with this Agreement, together with all other fees, expenses and reimbursement amounts due and payable to the Agent under Section 9 of this Agreement; and

(d)    such other documents, instruments and agreements as the Agent may reasonably request.

Section 4. Representations and Warranties. Each Loan Party hereby represents and warrants as follows:

(a)    at the time of and immediately after giving effect to this Agreement, all representations and warranties of each Loan Party set forth in the Loan Documents are true and correct in all material respects (other than those representations and warranties that are expressly qualified by a Material Adverse Effect or other materiality, in which case such representations and warranties are true and correct in all respects) on and as of the date of this Agreement, in each case before and after giving effect thereto, except to the extent made as of a specific date (in which case such representations and warranties shall be true and correct in all material respects (or all respects, as applicable) as of such date);

(b)    the execution, delivery and performance by such Loan Party of this Agreement are within such Loan Party’s organizational powers and have been duly authorized by all necessary organizational and, if required, shareholder, partner or member action and (i) do not require any consent or approval of, registration or filing with, or any action by, any Governmental Authority, except those as have been obtained or made and are in full force and effect and except for filings necessary to perfect or maintain perfection of the Liens created under the Loan Documents, (ii) will not violate any Requirement of Law applicable to the REIT Guarantor, the Borrower or any Subsidiary Loan Party or any judgment, order or ruling of any Governmental Authority, (iii) will not violate or result in a default under any Contractual Obligation of the REIT Guarantor, the Borrower or any Subsidiary Loan Party or give rise to a right thereunder to require any payment to be made by the REIT Guarantor, the Borrower or any Subsidiary Loan Party and (iv) will not result in the creation or imposition of any Lien on any asset of the REIT

Guarantor, the Borrower or any Subsidiary Loan Party, except Liens (if any) created under the Loan Documents;

(c)     this Agreement has been duly executed and delivered by such Loan Party, and constitutes a valid and binding obligation of such Loan Party, enforceable against it in accordance with its terms except as may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting the enforcement of creditors’ rights generally and by general principles of equity; and

(d)     on and as of the date hereof and immediately after giving effect to this Agreement, no Default or Event of Default exists.

Section 5. No Further Waivers; Ratification of Liability. Except as expressly waived hereby, the Credit Agreement and each of the other Loan Documents shall remain in full force and effect in accordance with their respective terms. Each Loan Party hereby ratifies, confirms and reaffirms its respective liabilities, payment and performance obligations (contingent or otherwise) and agreements under the Credit Agreement and the other Loan Documents to which it is a party, and the liens and security interests granted, created and perfected thereby. This Agreement shall not constitute a modification of the Credit Agreement or a course of dealing with the Agent or any Lender at variance with the Credit Agreement such as to require further notice by the Agent or any Lender to require strict compliance with the terms of the Credit Agreement and the other Loan Documents in the future, except as expressly set forth herein. This Agreement contains the entire agreement among the Loan Parties and the Lenders contemplated by this Agreement. No Loan Party has any knowledge of any challenge to the Agent’s or any Lender’s claims arising under the Loan Documents or the effectiveness of the Loan Documents. Except as expressly set forth in the foregoing waiver, the Agent and the Lenders reserve all rights, privileges and remedies under the Loan Documents.

Section 6. No Novation. Nothing in this Agreement is intended, or shall be construed, to constitute a novation or an accord and satisfaction of any of the Obligations or to modify, affect or impair the perfection, priority or continuation of the security interests in, security titles to or other Liens on any Collateral for the Obligations.

Section 7. Release. In consideration of the waivers contained herein, each of the Loan Parties hereby waives and releases the Lenders, the Agent, the Swingline Lender and the Issuing Bank from any and all claims and defenses, known or unknown, existing on the date hereof with respect to the Credit Agreement and the other Loan Documents and the transactions contemplated thereby.

Section 8. Further Assurances. The REIT Guarantor and the Borrower agree to take all further actions and execute such other documents and instruments as the Agent may from time to time reasonably request to carry out the transactions contemplated by this Agreement, the Loan Documents and all other agreements executed and delivered in connection herewith.

Section 9. Costs and Expenses. The REIT Guarantor and the Borrower agree to pay on demand all reasonable, documented out-of-pocket costs and expenses incurred in connection with the preparation, execution and delivery of this Agreement and the other instruments and documents to be delivered hereunder or in connection with the Credit Agreement with respect to the matters covered hereby, including, without limitation, the reasonable, documented fees, charges and disbursements of counsel for the Agent with respect thereto and with respect to advising the Agent as to its rights and responsibilities hereunder and thereunder.

Section 10. Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of New York.

Section 11. Loan Document. This Agreement shall be deemed to be a Loan Document for all purposes.

Section 12. Affirmation of Guaranty. By executing this Agreement, the REIT Guarantor and the Subsidiary Loan Parties each hereby acknowledges, consents and agrees that all of its obligations and liabilities under the Guaranty and Security Agreement remain in full force and effect, and that the execution and delivery of this Agreement and any and all documents executed in connection herewith shall not alter, amend, reduce or modify

its obligations and liability under the Guaranty and Security Agreement or any of the other Loan Documents to which it is a party.

Section 13. Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be deemed an original and all of which, taken together, shall constitute one and the same instrument. Delivery of an executed counterpart to this Agreement by facsimile or other electronic method of transmission shall be as effective as delivery of a manually executed counterpart hereof.

Section 14. Severability. In case any provision of or obligation under this Agreement shall be invalid, illegal or unenforceable in any jurisdiction, the validity, legality and enforceability of the remaining provisions or obligations, or of such provision or obligation in any other jurisdiction, shall not in any way be affected or impaired thereby.

Section 15. Headings. Headings and captions used in this Agreement are included for convenience of reference only and shall not be given any substantive effect.

[Signatures on Next Page]

IN WITNESS WHEREOF, the parties hereto have caused this First Amendment to Second Amended and Restated Credit Agreement to be duly executed as of the date first above written.

BORROWER: COMMUNITY HEALTHCARE OP, LP

By: /s/ W. Page Barnes

Name: W. Page Barnes

Title: Chief Financial Officer

REIT GUARANTOR:                COMMUNITY HEALTHCARE TRUST

                         INCORPORATED

By: /s/ W. Page Barnes

Name: W. Page Barnes

Title: Chief Financial Officer

SUBSIDIARY LOAN PARTIES:        CHCT ALABAMA, LLC

CHCT ARIZONA, LLC

CHCT COLORADO, LLC

CHCT FLORIDA, LLC

CHCT GEORGIA, LLC

CHCT IDAHO, LLC

CHCT ILLINOIS, LLC

CHCT INDIANA, LLC

CHCT KANSAS, LLC

CHCT KENTUCKY, LLC

CHCT LENDING, LLC

CHCT LOUISIANA, LLC

CHCT MARYLAND, LLC

CHCT MICHIGAN, LLC

CHCT MISSISSIPPI, LLC

CHCT NEW YORK, LLC

CHCT OHIO, LLC

CHCT OKLAHOMA, LLC

CHCT PENNSYLVANIA, LLC

CHCT SOUTH CAROLINA, LLC

CHCT TENNESSEE, LLC

CHCT TEXAS, LLC

CHCT VIRGINIA, LLC

CHCT WISCONSIN, LLC

COMMUNITY HEALTHCARE TRUST, LLC

COMMUNITY HEALTHCARE TRUST SERVICES, INC.

CHCT CALIFORNIA, LLC

CHCT WEST VIRGINIA, LLC

By: /s/ W. Page Barnes

Name: W. Page Barnes

Title: Chief Financial Officer

4830-6945-5708 v3

2927475-000042 02/09/2018

AGENT

AND LENDERS: SUNTRUST BANK, as Agent, as the Issuing Bank, as the Swingline Lender and as a Lender

By: /s/ Jared Cohen

Name: Jared Cohen

Title: Vice President

FIFTH THIRD BANK, as a Lender

By: /s/ Vera B. McEvoy

Name: Vera B. McEvoy

Title: Director II

CADENCE BANK, N.A., as a Lender

By: /s/ William H. Crawford

Name: William H. Crawford

Title: Executive Vice President

FIRST TENNESSEE BANK, NA, as a Lender

By: /s/ Cathy Wind

Name: Cathy Wind

Title: SVP

FRANKLIN SYNERGY BANK, as a Lender

By:/s/ Timothy B. Fouts (per Amanda Kolesaui)

Name: Timothy B. Fouts

Title: EVP

BANCORPSOUTH, as a Lender

By: /s/ Randall P. Robinson

Name: Randall P. Robinson

Title: Sr. Vice President

CAPSTAR BANK, as a Lender

By: /s/ David A. Bertauf

Name: David A. Bertauf

Title: SVP, Healthcare Group

4830-6945-5708 v3

2927475-000042 02/09/2018

PINNACLE BANK, as a Lender

By: /s/ Allison Jones

Name: Allison Jones

Title: Senior Vice President

SYNOVUS BANK, as a Lender

By: /s/ David. W. Bowman

Name: David W. Bowman

Title: Director

BRANCH BANKING AND TRUST COMPANY, as a Lender

By:/s/ Brian Waldron

Name: Brian Waldron

Title:Vice President

4830-6945-5708 v3

2927475-000042 02/09/2018

EX-31.1

Exhibit 31.1

Community Healthcare Trust Incorporated

Quarterly Certification

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Timothy G. Wallace, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Community Healthcare Trust Incorporated;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: May 8, 2018

/s/ Timothy G. Wallace

Timothy G. Wallace

Chief Executive Officer and President

EX-31.2

Exhibit 31.2

Community Healthcare Trust Incorporated

Quarterly Certification

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, W. Page Barnes, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Community Healthcare Trust Incorporated;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: May 8, 2018

/s/ W. Page Barnes

W. Page Barnes

Executive Vice President and Chief Financial Officer

EX-32.1

Exhibit 32.1

Community Healthcare Trust Incorporated

Certification Pursuant to

18 U.S.C. Section 1350,

as Adopted Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report on Form 10-Q of Community Healthcare Trust Incorporated (the "Company") for the period ended March 31, 2018, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Timothy G. Wallace, Chief Executive Officer and President of the Company, and I, W. Page Barnes, Executive Vice President and Chief Financial Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 8, 2018

/s/ Timothy G. Wallace

Timothy G. Wallace

Chief Executive Officer and President

/s/ W. Page Barnes

W. Page Barnes

Executive Vice President and Chief Financial Officer

EX-99.1

Exhibit 99.1

SECOND AMENDMENT TO SECOND AMENDED AND RESTATED CREDIT AGREEMENT

THIS SECOND AMENDMENT TO SECOND AMENDED AND RESTATED CREDIT AGREEMENT dated as of March 27, 2018 (the “Agreement”), is executed by each of the Lenders hereto, SUNTRUST BANK, as Agent (the “Agent”), COMMUNITY HEALTHCARE OP, LP, a Delaware limited partnership (the “Borrower”), COMMUNITY HEALTHCARE TRUST INCORPORATED, a Maryland corporation (the “REIT Guarantor”), the Subsidiary Loan Parties and the other parties hereto.

WHEREAS, the Borrower, the REIT Guarantor, the financial institutions signatory thereto and their assignees thereunder (the “Lenders”), the Agent, and the other parties thereto, have entered into that certain Second Amended and Restated Credit Agreement dated as of March 29, 2017 (as amended, restated, supplemented or otherwise modified from time to time, the “Credit Agreement”); and

WHEREAS, the Borrower and REIT Guarantor have requested to make certain amendments to the Credit Agreement as set forth herein and the Agent and the Lenders have agreed to such amendments on the terms and conditions set forth herein.

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which hereby are acknowledged by the parties hereto, the parties hereto hereby agree as follows:

Section 1. Specific Amendments to Credit Agreement. Subject to the satisfaction of the conditions precedent set forth in Section 2 below, the parties hereto agree that the Credit Agreement is amended as follows:

(a)    Section 1.1 of the Credit Agreement is further amended by restating the definition of “Swingline Commitment” in its entirety as follows:

“Swingline Commitment” shall mean the commitment of the Swingline Lender to make Swingline Loans in an aggregate principal amount at any time outstanding not to exceed $20,000,000.    

(b)    Section 1.1 of the Credit Agreement is further amended by replacing the table in the definition of “Applicable Margin” in its entirety with the following:

Pricing Grid
Level	Leverage Ratio	Applicable Margin for Revolving Loans that are Eurodollar Loans	Applicable Margin for Revolving Loans that are Base Rate Loans	Applicable Margin for A-1 Term Loans that are Eurodollar Loans	Applicable Margin for A-1 Term Loans that are Base Rate Loans	Applicable Margin for A-2 Term Loans that are Eurodollar Loans	Applicable Margin for A-2 Term Loans that are Base Rate Loans
1	Less than or equal to 0.20 to 1.00	1.75%	0.75%	1.95%	0.95%	2.15%	1.15%
2	Less than or equal to 0.40 to 1.00 and greater than 0.20 to 1.00	2.00%	1.00%	1.95%	0.95%	2.15%	1.15%
3	Greater than 0.40 to 1.00	2.50%	1.50%	2.45%	1.45%	2.65%	1.65%

Section 2. Conditions Precedent. The effectiveness of this Agreement is subject to receipt by the Agent of each of the following, each in form and substance reasonably satisfactory to the Agent:

(a)    a counterpart of this Agreement duly executed by the Borrower, the REIT Guarantor, the Agent and all Lenders;

(b)    a certificate signed by a Responsible Officer and the chief financial officer of the REIT Guarantor and the Borrower, certifying that, after giving effect to the transactions contemplated hereby, that (i) no Default or Event of Default shall be in existence on the date hereof and (ii) each representation and warranty made or deemed made by the Borrower or any other Loan Party in each Loan Document to which any such Loan Party is a party is true and correct in all material respects (or in the case of representations and warranties that are expressly qualified by a Material Adverse Effect or other materiality qualifier, in all respects) on the date hereof except to the extent that such representations and warranties expressly related solely to an earlier date (in which case such representations and warranties shall have been true and correct in all material respects (or in the case of representations and warranties that are expressly qualified by a Material Adverse Effect or other materiality qualifier, in all respects) on and as of such earlier date);

(c)    evidence that all fees then due and payable by the Borrower in connection with this Agreement, together with all other fees, expenses and reimbursement amounts due and payable to the Agent under Section 8 of this Agreement; and

(d)    such other documents, instruments and agreements as the Agent may reasonably request.

Section 3 Representations and Warranties. Each Loan Party hereby represents and warrants as follows:

(a)    at the time of and immediately after giving effect to this Agreement, all representations and warranties of each Loan Party set forth in the Loan Documents are true and correct in all material respects (other than those representations and warranties that are expressly qualified by a Material Adverse Effect or other materiality, in which case such representations and warranties are true and correct in all respects) on and as of the date of this Agreement, in each case before and after giving effect thereto, except to the extent made as of a specific date (in which case such representations and warranties shall be true and correct in all material respects (or all respects, as applicable) as of such date);

(b)    the execution, delivery and performance by such Loan Party of this Agreement are within such Loan Party’s organizational powers and have been duly authorized by all necessary organizational and, if required, shareholder, partner or member action and (i) do not require any consent or approval of, registration or filing with, or any action by, any Governmental Authority, except those as have been obtained or made and are in full force and effect and except for filings necessary to perfect or maintain perfection of the Liens created under the Loan Documents, (ii) will not violate any Requirement of Law applicable to the REIT Guarantor, the Borrower or any Subsidiary Loan Party or any judgment, order or ruling of any Governmental Authority, (iii) will not violate or result in a default under any Contractual Obligation of the REIT Guarantor, the Borrower or any Subsidiary Loan Party or give rise to a right thereunder to require any payment to be made by the REIT Guarantor, the Borrower or any Subsidiary Loan Party and (iv) will not result in the creation or imposition of any Lien on any asset of the REIT Guarantor, the Borrower or any Subsidiary Loan Party, except Liens (if any) created under the Loan Documents;

(c)     this Agreement has been duly executed and delivered by such Loan Party, and constitutes a valid and binding obligation of such Loan Party, enforceable against it in accordance with its terms except as may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting the enforcement of creditors’ rights generally and by general principles of equity; and

(d)     on and as of the date hereof and immediately after giving effect to this Agreement, no Default or Event of Default exists.

Section 4. No Further Waivers; Ratification of Liability. Except as expressly waived hereby, the Credit Agreement and each of the other Loan Documents shall remain in full force and effect in accordance with their respective terms. Each Loan Party hereby ratifies, confirms and reaffirms its respective liabilities, payment and performance obligations (contingent or otherwise) and agreements under the Credit Agreement and the other Loan Documents to which it is a party, and the liens and security interests granted, created and perfected thereby. This Agreement shall not constitute a modification of the Credit Agreement or a course of dealing with the Agent or any Lender at variance with the Credit Agreement such as to require further notice by the Agent or any Lender to require strict compliance with the terms of the Credit Agreement and the other Loan Documents in the future, except as expressly set forth herein. This Agreement contains the entire agreement among the Loan Parties and the Lenders contemplated by this Agreement. No Loan Party has any knowledge of any challenge to the Agent’s or any Lender’s claims arising under the Loan Documents or the effectiveness of the Loan Documents. Except as expressly set forth in the foregoing waiver, the Agent and the Lenders reserve all rights, privileges and remedies under the Loan Documents.

Section 5. No Novation. Nothing in this Agreement is intended, or shall be construed, to constitute a novation or an accord and satisfaction of any of the Obligations or to modify, affect or impair the perfection, priority or continuation of the security interests in, security titles to or other Liens on any Collateral for the Obligations.

Section 6. Release. In consideration of the waivers contained herein, each of the Loan Parties hereby waives and releases the Lenders, the Agent, the Swingline Lender and the Issuing Bank from any and all claims and defenses, known or unknown, existing on the date hereof with respect to the Credit Agreement and the other Loan Documents and the transactions contemplated thereby.

Section 7. Further Assurances. The REIT Guarantor and the Borrower agree to take all further actions and execute such other documents and instruments as the Agent may from time to time reasonably request to carry out the transactions contemplated by this Agreement, the Loan Documents and all other agreements executed and delivered in connection herewith.

Section 8. Costs and Expenses. The REIT Guarantor and the Borrower agree to pay on demand all reasonable, documented out-of-pocket costs and expenses incurred in connection with the preparation, execution and delivery of this Agreement and the other instruments and documents to be delivered hereunder or in connection with the Credit Agreement with respect to the matters covered hereby, including, without limitation, the reasonable, documented fees, charges and disbursements of counsel for the Agent with respect thereto and with respect to advising the Agent as to its rights and responsibilities hereunder and thereunder.

Section 9. Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of New York.

Section 10. Loan Document. This Agreement shall be deemed to be a Loan Document for all purposes.

Section 11. Affirmation of Guaranty. By executing this Agreement, the REIT Guarantor and the Subsidiary Loan Parties each hereby acknowledges, consents and agrees that all of its obligations and liabilities under the Guaranty and Security Agreement remain in full force and effect, and that the execution and delivery of this Agreement and any and all documents executed in connection herewith shall not alter, amend, reduce or modify its obligations and liabilities under the Guaranty and Security Agreement or any of the other Loan Documents to which it is a party.

Section 12. Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be deemed an original and all of which, taken together, shall constitute one and the same instrument. Delivery of an executed counterpart to this Agreement by facsimile or other electronic method of transmission shall be as effective as delivery of a manually executed counterpart hereof.

Section 13. Severability. In case any provision of or obligation under this Agreement shall be invalid, illegal or unenforceable in any jurisdiction, the validity, legality and enforceability of the remaining provisions or obligations, or of such provision or obligation in any other jurisdiction, shall not in any way be affected or impaired thereby.

Section 14. Headings. Headings and captions used in this Agreement are included for convenience of reference only and shall not be given any substantive effect.

[Signatures on Next Page]

IN WITNESS WHEREOF, the parties hereto have caused this Second Amendment to Second Amended and Restated Credit Agreement to be duly executed as of the date first above written.

BORROWER: COMMUNITY HEALTHCARE OP, LP

By: /s/ W. Page Barnes

Name: W. Page Barnes

Title: Chief Financial Officer

REIT GUARANTOR:                COMMUNITY HEALTHCARE TRUST

                         INCORPORATED

By:/s/ W. Page Barnes

Name: W. Page Barnes

Title: Chief Financial Officer

SUBSIDIARY LOAN PARTIES:            CHCT ALABAMA, LLC

CHCT ARIZONA, LLC

CHCT COLORADO, LLC

CHCT FLORIDA, LLC

CHCT GEORGIA, LLC

CHCT IDAHO, LLC

CHCT ILLINOIS, LLC

CHCT INDIANA, LLC

CHCT IOWA, LLC

CHCT KANSAS, LLC

CHCT KENTUCKY, LLC

CHCT LENDING, LLC

CHCT LOUISIANA, LLC

CHCT MARYLAND, LLC

CHCT MICHIGAN, LLC

CHCT MISSISSIPPI, LLC

CHCT NEVADA, LLC

CHCT NEW JERSEY, LLC

CHCT NEW YORK, LLC

CHCT NORTH CAROLINA, LLC

CHCT OHIO, LLC

CHCT OKLAHOMA, LLC

CHCT PENNSYLVANIA, LLC

CHCT SOUTH CAROLINA, LLC

CHCT TENNESSEE, LLC

CHCT TEXAS, LLC

CHCT VIRGINIA, LLC

CHCT WISCONSIN, LLC

COMMUNITY HEALTHCARE TRUST, LLC

COMMUNITY HEALTHCARE TRUST SERVICES, INC.

CHCT CALIFORNIA, LLC

CHCT WEST VIRGINIA, LLC

By: /s/ W. Page Barnes

Name: W. Page Barnes

Title: Chief Financial Officer

AGENT

AND LENDERS: SUNTRUST BANK, as Agent, as the Issuing Bank, as the Swingline Lender and as a Lender

By: /s/ Jared Cohen

Name: Jared Cohen

Title: Vice President

FIFTH THIRD BANK, as a Lender

By:/s/ Vera B. McEvoy

Name: Vera B. McEvoy

Title: Director II

FIRST TENNESSEE BANK, NA, as a Lender

By:/s/ Cathy Wind

Name: Cathy Wind

Title: SVP

BRANCH BANKING AND TRUST COMPANY, as a Lender

By: /s/ Ahaz Armstrong

Name: Ahaz Armstrong

Title: Senior Vice President

CADENCE BANK, N.A., as a Lender

By:/s/ John R. Burch III

Name: John R. Burch III

Title: AVP

CAPSTAR BANK, as a Lender

By: /s/ David A. Bertani

Name: David A. Bertani

Title: SVP, Healthcare Group

FRANKLIN SYNERGY BANK, as a Lender

By: /s/ Timothy B. Fouts

Name: Timothy B. Fouts

Title: Executive Vice President

PINNACLE BANK, as a Lender

By: /s/ Allison Jones

Name: Allison Jones

Title: SVP

SYNOVUS BANK, as a Lender

By:/s/ David W. Bowman

Name: David W. Bowman

Title: Director, Corporate Banking

BANCORPSOUTH, as a Lender

By: /s/ Randall P. Robinson

Name: Randall P. Robinson

Title: Sr. Vice President

XML

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2018	May 03, 2018
Document and Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2018
Document Fiscal Year Focus	2018
Document Fiscal Period Focus	Q1
Entity Registrant Name	Community Healthcare Trust Inc
Entity Central Index Key	0001631569
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		18,179,799

XML

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2018	Dec. 31, 2017
Real estate properties
Land and land improvements	$ 46,066	$ 44,419
Buildings, improvements, and lease intangibles	356,530	343,955
Personal property	116	112
Total real estate properties	402,712	388,486
Less accumulated depreciation	(41,052)	(36,136)
Total real estate properties, net	361,660	352,350
Cash and cash equivalents	2,285	2,130
Mortgage note receivable, net	10,633	10,633
Other assets, net	25,210	20,653
Total assets	399,788	385,766
Liabilities
Debt, net	111,385	93,353
Accounts payable and accrued liabilities	3,806	4,056
Other liabilities	4,987	4,983
Total liabilities	120,178	102,392
Commitments and contingencies
Stockholders' Equity
Preferred stock, $0.01 par value; 50,000,000 shares authorized; none issued and outstanding	0	0
Common stock, $0.01 par value; 450,000,000 shares authorized; 18,179,799 and 18,085,798 shares issued and outstanding at March 31, 2018 and December 31, 2017, respectively	182	181
Additional paid-in capital	324,918	324,303
Cumulative net income	6,647	4,775
Accumulated other comprehensive income	1,232	258
Cumulative dividends	(53,369)	(46,143)
Total stockholders’ equity	279,610	283,374
Total liabilities and stockholders' equity	$ 399,788	$ 385,766

XML

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2018	Dec. 31, 2017
Statement of Financial Position [Abstract]
Preferred Stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred Stock, shares authorized	50,000,000	50,000,000
Preferred Stock, shares issued	0	0
Preferred Stock, shares outstanding	0	0
Common Stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common Stock, shares authorized	450,000,000	450,000,000
Common Stock, shares issued	18,179,799	18,085,798
Common Stock, shares outstanding	18,179,799	18,085,798

XML

Condensed Consolidated Statements of Income - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
REVENUES
Rental income	$ 9,635	$ 6,618
Tenant reimbursements	1,440	1,128
Mortgage interest	0	261
Other operating	354	0
Revenues	11,429	8,007
EXPENSES
Property operating	2,364	1,738
General and administrative	1,193	770
Depreciation and amortization	4,916	3,924
Bad debts	0	67
Expenses	8,473	6,499
OTHER INCOME (EXPENSE)
Interest expense	(1,268)	(597)
Interest and other income, net	184	2
Other Income (Expense)	(1,084)	(595)
NET INCOME	$ 1,872	$ 913
NET INCOME PER COMMON SHARE:
Net income per common share – Basic (in dollars per share)	$ 0.09	$ 0.07
Net income per common share – Diluted (in dollars per share)	$ 0.09	$ 0.07
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING-BASIC (in shares)	17,573,683	12,686,183
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING-DILUTED (in shares)	17,573,683	12,819,496
DIVIDENDS DECLARED, PER COMMON SHARE, DURING THE PERIOD (in dollars per share)	$ 0.3975	$ 0.3875

XML

Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Statement of Comprehensive Income [Abstract]
NET INCOME	$ 1,872	$ 913
Other comprehensive income (loss):
Increase (decrease) in fair value of cash flow hedges	906	(158)
Reclassification for amounts recognized as interest expense	68	6
Total other comprehensive income (loss)	974	(152)
COMPREHENSIVE INCOME	$ 2,846	$ 761

XML

Condensed Consolidated Statements of Stockholders' Equity - 3 months ended Mar. 31, 2018 - USD ($) $ in Thousands	Total	Preferred Stock [Member]	Common Stock [Member]	Additional Paid in Capital [Member]	Cumulative Net Income [Member]	Accumulated Other Comprehensive Income [Member]	Cumulative Dividends [Member]
Beginning Balance at Dec. 31, 2017	$ 283,374	$ 0	$ 181	$ 324,303	$ 4,775	$ 258	$ (46,143)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	616		1	615
Unrecognized gain on cash flow hedges	906					906
Reclassification adjustment for losses included in net income (interest expense)	68					68
Net income	1,872				1,872
Dividends to common stockholders ($0.3975 per share)	(7,226)						(7,226)
Ending Balance at Mar. 31, 2018	$ 279,610	$ 0	$ 182	$ 324,918	$ 6,647	$ 1,232	$ (53,369)

XML

Condensed Consolidated Statements of Stockholders' Equity (Parenthetical)	3 Months Ended
	Mar. 31, 2018 $ / shares
Cumulative Dividends [Member]
Dividends to common stockholders, per share (in dollars per share)	$ 0.3975

XML

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Statement of Cash Flows [Abstract]
Net income	$ 1,872	$ 913
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	5,133	3,998
Stock-based compensation	616	318
Straight-line rent receivable	(415)	(265)
Provision for bad debts, net of recoveries	0	67
Reduction in contingent purchase price	0	(5)
Deferred income tax benefit	(132)	0
Changes in operating assets and liabilities:
Other assets	(696)	32
Accounts payable and accrued liabilities	(309)	(578)
Other liabilities	(121)	75
Net cash provided by operating activities	5,948	4,555
INVESTING ACTIVITIES
Acquisitions of real estate	(12,721)	(29,311)
Acquisitions of notes receivable	(2,201)	0
Proceeds from the repayment of notes receivable	17	140
Capital expenditures on existing real estate properties	(1,444)	(64)
Net cash used in investing activities	(16,349)	(29,235)
FINANCING ACTIVITIES
Net repayments on revolving credit facility	(22,000)	(29,000)
Term loan borrowings	40,000	60,000
Dividends paid	(7,226)	(5,078)
Debt issuance costs	(218)	(766)
Net cash provided by financing activities	10,556	25,156
Increase in cash and cash equivalents	155	476
Cash and cash equivalents, beginning of period	2,130	1,568
Cash and cash equivalents, end of period	2,285	2,044
Supplemental Cash Flow Information:
Interest paid	1,105	780
Invoices accrued for construction, tenant improvement and other capitalized costs	712	46
Increase (decrease) in fair value of cash flow hedges	$ 906	$ (158)

XML

Summary of Significant Accounting Policies

3 Months Ended

Mar. 31, 2018

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Summary of Significant Accounting Policies

Business Overview

Community Healthcare Trust Incorporated (the ‘‘Company’’, ‘‘we’’, ‘‘our’’) was organized in the State of Maryland on March 28, 2014. The Company is a fully-integrated healthcare real estate company that owns and acquires real estate properties that are leased to hospitals, doctors, healthcare systems or other healthcare service providers in our target submarkets. The Company conducts its business through an UPREIT structure in which its properties are owned by its operating partnership (the "OP"), either directly or through subsidiaries. The Company is the sole general partner of the OP, owning 100% of the OP units. As of March 31, 2018, the Company had investments of approximately $413.3 million in 89 real estate properties, including a mortgage note, located in 27 states, totaling approximately 2.0 million square feet in the aggregate.

Basis of Presentation

The Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. They do not include all of the information and footnotes required by GAAP for complete financial statements.

This interim financial information should be read in conjunction with the financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017.

Management believes that all adjustments of a normal, recurring nature considered necessary for a fair presentation have been included. This interim financial information does not necessarily represent or indicate what the operating results will be for the year ending December 31, 2018. All material intercompany accounts and transactions have been eliminated.

Use of Estimates in the Condensed Consolidated Financial Statements

Preparation of the Condensed Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect amounts reported in the Condensed Consolidated Financial Statements and accompanying notes. Actual results may materially differ from those estimates.

Income Taxes

The Company has elected to be taxed as a real estate investment trust ("REIT"), as defined under the Internal Revenue Code of 1986, as amended (the "Code"). The Company and one subsidiary have also elected for that subsidiary to be treated as a taxable REIT subsidiary ("TRS"), which is subject to federal and state income taxes. No provision has been made for federal income taxes for the REIT; however, the Company may record income tax expense or benefit for the TRS to the extent applicable. The Company intends at all times to qualify as a REIT under the Code. The Company must distribute at least 90% per annum of its REIT taxable income to its stockholders (which is computed without regard to the dividends paid deduction or net capital gain and which does not necessarily equal net income as calculated in accordance with GAAP) and meet other requirements to continue to qualify as a REIT.

Effective January 1, 2018, under legislation from the Tax Cuts and Jobs Act of 2017, the maximum U.S. federal corporate income tax rate was reduced from 35% to 21%. Accordingly, to the extent that the activities of our taxable REIT subsidiary generates taxable income in future periods, it may be subject to lower U.S. federal income tax rates.

The Company classifies interest and penalties related to uncertain tax positions, if any, in the Condensed Consolidated Statements of Income as a component of general and administrative expenses.

New Accounting Pronouncements

In May 2014, the FASB issued Accounting Standards Update 2014-09, Revenue from Contracts with Customers ("ASU 2014-09"), which establishes a comprehensive model to account for revenues arising from contracts with customers. ASU 2014-09 applies to all contracts with customers, except those that are within the scope of other topics in the FASB's Accounting Standards Codification, such as real estate leases and financial instruments. ASU 2014-09 requires companies to perform a five-step analysis of transactions to determine when and how revenue is recognized. The Company adopted ASU 2014-09 using the "modified retrospective" method effective January 1, 2018; as such, the Company applied the guidance only to the most recent period presented in the financial statements. The primary source of revenue for the Company is generated through its leasing arrangements with its tenants, which is covered under other accounting guidance, but certain non-lease revenues could be impacted by the new guidance. While the Company has not historically sold any properties, accounting for the sales of real estate could also be impacted by this new guidance. Prior to the adoption of ASU 2014-09, gains and losses from real estate sales were adjusted at the time of the sale by the maximum exposure to loss related to continuing involvement with the real estate. After adoption, any continuing involvement is considered a separate performance obligation and the sales price is required to be allocated between the elements with continuing involvement and those without continuing involvement. As the continuing performance obligations are satisfied, additional gains and losses will be recognized. The Company recognized no change to previously reported amounts from the cumulative effect of the adoption of ASU 2014-09.

On January 1, 2018, the Company adopted ASU No. 2016-15, Statement of Cash Flows (Topic 230) Classification of Certain Cash Receipts and Cash Payments, ("ASU 2016-15"), which clarifies or provides guidance relating to eight specific cash flow classification issues. The standard should be applied retrospectively for each period presented, as appropriate. The impact of this new guidance will depend on future transactions, though the impact will only be related to the classification of those items on the statement of cash flows and will not impact the Company's total cash flows or its results of operations. There was no impact to the Company's Consolidated Financial Statements upon adoption of this standard.

On January 1, 2018, the Company adopted ASU No. 2017-09, Compensation - Stock Compensation (Topic 718), ("ASU 2017-09"), which provides guidance about which changes in the terms or conditions of a share-based payment award require a company to apply modification accounting in Topic 718. Under ASU No. 2017-09, a company will generally be required to apply modification accounting unless the fair value or intrinsic value of the modified award, the vesting conditions of the modified award, and the classification of the modified award as equity or a liability are the same as the original award immediately before the award is modified. There was no impact to the Company's Consolidated Financial Statements upon adoption of this standard.

In February 2016, the FASB issued ASU No. 2016-02, Leases, ("ASU 2016-02"). This standard requires a lessor to classify leases as either sales-type, finance or operating. A lease will be treated as a sale if it transfers all of the risks and rewards, as well as control of the underlying asset, to the lessee. If risks and rewards are conveyed without the transfer of control, the lease is treated as a financing lease. If the lessor doesn’t convey risks and rewards or control, an operating lease results. ASU 2016-02 is effective for fiscal years, and interim periods within, beginning after December 15, 2018. Early adoption is permitted. A modified retrospective transition approach is required for lessors for sales-type, direct financing, and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. Leasing revenues will continue to be recognized on a straight-line basis over the lease term, while certain reimbursable costs currently reflected on a net basis in the financial statements may require presentation on a gross basis under the new standard. Additionally, certain non-lease components may be accounted for under the new revenue recognition guidance in the Revenue ASUs. The Company may also be impacted by this new accounting guidance related to ground leases in which the Company would be the lessee. Pursuant to the new accounting guidance, lessees are required to record a right-of-use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. The Company is still evaluating the complete impact of the adoption of ASU 2016-02 on January 1, 2019 to its consolidated financial position, results of operations and disclosures.

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments-Credit Losses, ("ASU 2016-13"), which changes the impairment model for most financial assets and certain other instruments. For trade and other receivables, held-to-maturity debt securities, loans and other instruments, companies will be required to use a new forward-looking “expected loss” model that generally will result in the earlier recognition of allowances for losses. For available-for-sale debt securities with unrealized losses, companies will measure credit losses in a manner similar to what they do today, except that the losses will be recognized as allowances rather than as reductions in the amortized cost of the securities. Companies will have to disclose significantly more information, including information they use to track credit quality by year of origination for most financing receivables. Companies will apply the standard’s provisions as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is adopted. This standard is effective for the Company on January 1, 2020 with early adoption permitted. The Company is in the initial stage of evaluating the impact of this new standard on its notes and trade receivables.

XML

Real Estate Investments

3 Months Ended

Mar. 31, 2018

Real Estate [Abstract]

Real Estate Investments

Real Estate Investments

At March 31, 2018, the Company had investments of approximately $413.3 million in 89 real estate properties, including one mortgage note. The following table summarizes the Company's real estate investments.

(Dollars in thousands)	Number of Facilities	Land and Land Improvements		Buildings, Improvements, and Lease Intangibles		Personal Property		Total		Accumulated Depreciation
Medical office buildings:
Florida	5	$	4,608	$	29,241	$	—	$	33,849	$	2,896
Ohio	5	3,167		23,527		—		26,694		3,951
Texas	3	3,096		13,898		—		16,994		3,579
Illinois	2	1,134		11,823		—		12,957		1,803
Kansas	2	1,427		10,497		—		11,924		2,541
Iowa	1	2,241		9,004		—		11,245		1,412
Other states	14	3,642		27,365		—		31,007		2,898
	32	19,315		125,355		—		144,670		19,080
Physician clinics:
Kansas	3	1,638		10,909		—		12,547		2,157
Illinois	2	2,615		6,354		—		8,969		151
Florida	4	253		9,484		—		9,737		568
Other states	9	3,194		18,472		—		21,666		3,316
	18	7,700		45,219		—		52,919		6,192
Surgical centers and hospitals:
Louisiana	1	1,683		21,353		—		23,036		711
Indiana	1	523		14,405		—		14,928		532
Michigan	2	628		8,272		—		8,900		2,057
Illinois	1	2,183		5,410		—		7,593		847
Florida	1	271		7,017		—		7,288		347
Arizona	2	576		5,389		—		5,965		1,127
Other states	5	1,555		11,000		—		12,555		3,046
	13	7,419		72,846		—		80,265		8,667
Specialty centers:
Illinois	3	3,482		24,717		—		28,199		519
Other states	16	2,609		29,913		—		32,522		4,930
	19	6,091		54,630		—		60,721		5,449
Behavioral facilities:
West Virginia	1	2,138		22,897		—		25,035		298
Illinois	1	1,300		18,803		—		20,103		862
Indiana	2	1,126		6,040		—		7,166		195
Other states	2	977		8,729		—		9,706		159
	6	5,541		56,469		—		62,010		1,514
Corporate property	—	—		2,011		116		2,127		150
Total owned properties	88	$	46,066	$	356,530	$	116	$	402,712	$	41,052
Mortgage note receivable	1	—		—		—		10,633		—
Total real estate investments	89	$	46,066	$	356,530	$	116	$	413,345	$	41,052

XML

Real Estate Leases

3 Months Ended

Mar. 31, 2018

Leases [Abstract]

Real Estate Leases

Real Estate Leases

The Company’s properties are generally leased pursuant to non-cancelable, fixed-term operating leases with expiration dates through 2034. The Company’s leases generally require the lessee to pay minimum rent, with fixed rent renewal terms or increases based on a Consumer Price Index and and may also include additional rent, which may include taxes (including property taxes), insurance, maintenance and other operating costs associated with the leased property.

Future minimum lease payments under the non-cancelable operating leases due the Company for the years ending December 31, as of March 31, 2018, are as follows (in thousands):

2018 (nine months ending December 31)	$	27,856
2019	34,317
2020	31,425
2021	28,128
2022	24,973
2023 and thereafter	147,484
	$	294,183

Straight-line rental income

Rental income is recognized as earned over the life of the lease agreement on a straight-line basis. Straight-line rent included in rental income was approximately $0.4 million and $0.3 million, respectively, for the three months ended March 31, 2018 and 2017.

Deferred revenue

Rent received but not yet earned is deferred until such time it is earned. Deferred revenue, included in other liabilities, was approximately $1.3 million and $1.1 million, respectively, at March 31, 2018 and December 31, 2017.

XML

Real Estate Acquisitions

3 Months Ended

Mar. 31, 2018

Business Combinations [Abstract]

Real Estate Acquisitions

Real Estate Acquisitions

Property Acquisitions

During the first quarter of 2018, the Company acquired three real estate properties totaling approximately 38,000 square feet for an aggregate purchase price and cash consideration of approximately $12.7 million. Upon acquisition, the properties were 100% leased in the aggregate with lease expirations ranging from 2018 through 2033. Amounts reflected in revenues and net income for the three months ended March 31, 2018 for these properties was approximately $20,230 and $13,415, respectively. Transaction costs totaling approximately $101,000 related to these acquisitions were capitalized in the period and included, as applicable, in real estate assets or other assets.

XML

Mortgage Note Receivable

3 Months Ended

Mar. 31, 2018

Mortgage Loans on Real Estate [Abstract]

Mortgage Note Receivable

Mortgage Note Receivable

The Company had one mortgage note receivable outstanding as of March 31, 2018 and December 31, 2017 with a principal balance of $10.6 million and an interest receivable of $0.6 million. The borrower and several related entities (the "Borrower") filed for voluntary bankruptcy on June 23, 2017. At the time of filing for bankruptcy, the Borrower was current on all obligations to the Company, but no payments were received during the bankruptcy.

On December 28, 2017 the Company purchased $11.45 million face value of certain promissory notes, secured by accounts receivable of the Borrower, for $8.75 million from a syndicate of banks, a $2.7 million discount to face value, and in the first quarter of 2018 acquired $2.2 million of certain promissory notes, secured by the operations of two facilities related to the Borrower, but were not included in the bankruptcy, for a total investment in these promissory notes of approximately $10.95 million.

On April 25, 2018, the Company provided a new $23.0 million loan to a newly formed company (Newco), secured by all assets and ownership interests in seven long-term acute care hospitals and one inpatient rehabilitation hospital that, along with a series of investments by the management of Newco, allowed Newco to acquire certain assets of the Borrower.

Also on April 25, 2018, $10.95 million for the promissory notes discussed above and approximately $0.261 million of interest on those promissory notes and approximately $0.25 million in fees and reimbursement of expenses and approximately $6.7 million principal and accrued interest related to its mortgage note receivable were satisfied with proceeds from the new loan. In addition, the Company received title to the property previously financed by the mortgage note receivable at an approximate $4.5 million valuation, and the Company did not record interest on the mortgage note receivable during the first quarter of 2018. The Company does not believe that a material impairment exists, if any, at March 31, 2018, and therefore, has not recorded any impairment related to the bankruptcy.

XML

Debt, net

3 Months Ended

Mar. 31, 2018

Debt Disclosure [Abstract]

Debt, net

Debt, net

The table below details the Company's debt as of March 31, 2018 and December 31, 2017.

	Balance as of
(Dollars in thousands)	March 31, 2018		December 31, 2017		Maturity Dates
Revolving Credit Facility	$	12,000	$	34,000	8/19
5-Year Term Loan, net	49,703		29,685		3/22
7-Year Term Loan, net	49,682		29,668		3/24
	$	111,385	$	93,353

The Company's second amended and restated credit facility (the "Credit Facility") is by and among Community Healthcare OP, LP, the Company, the lenders from time to time party thereto, and SunTrust Bank, as Administrative Agent. The Company’s material subsidiaries are guarantors of the obligations under the Credit Facility. The Credit Facility provides for a $150.0 million revolving credit facility (the "Revolving Credit Facility") and $100.0 million in term loans (the "Term Loans"). The Credit Facility, through the accordion feature, allows borrowings up to a total of $450.0 million, including the ability to add and fund additional term loans. The Revolving Credit Facility matures on August 9, 2019 and includes two 12-month options to extend the maturity date of the Revolving Credit Facility, subject to the satisfaction of certain conditions. The Term Loans include a five-year term loan facility in the aggregate principal amount of $50.0 million (the "5-Year Term Loan") which matures on March 29, 2022 and a seven-year term loan facility in the aggregate principal amount of $50.0 million (the "7-Year Term Loan") which matures on March 29, 2024.

During the first quarter of 2018, the Company entered into two amendments relating to its Credit Facility. The first amendment, which was effective as of November 1, 2017, modified the formula used to calculate the amount of restricted payments the Company may make under the Credit Facility. The second amendment, effective on March 27, 2018, reduced the pricing margins on its LIBOR borrowings on both its Revolving Credit Facility and Term Loans and increased the maximum swingline commitment from $15.0 million to $20.0 million. The Company paid $0.2 million in fees related to these amendments.

Amounts outstanding under the Revolving Credit Facility, as amended, bear annual interest at a floating rate that is based, at the Company’s option, on either: (i) LIBOR plus 1.75% to 2.50% or (ii) a base rate plus 0.75% to 1.50%, in each case, depending upon the Company’s leverage ratio. In addition, the Company is obligated to pay an annual fee equal to 0.25% of the amount of the unused portion of the Revolving Credit Facility if amounts borrowed are greater than 33.3% of the borrowing capacity under the Revolving Credit Facility and 0.35% of the unused portion of the Revolving Credit Facility if amounts borrowed are less than or equal to 33.3% of the borrowing capacity under the Revolving Credit Facility. At March 31, 2018, the Company had $12.0 million outstanding under the Revolving Credit Facility with a remaining borrowing capacity of $138.0 million.

Amounts outstanding under the Term Loans, as amended, bear annual interest at a floating rate that is based, at the Company’s option, on either: (i) LIBOR plus 1.95% to 2.65% or (ii) a base rate plus 0.95% to 1.65%, in each case, depending upon the Company’s leverage ratio. In addition, the Company is obligated to pay an annual fee equal to 0.35% of the amount of the unused portion of the Term Loans. The Company entered into interest rate swaps to fix the interest rates on the original Term Loan amounts drawn in 2017. On March 29, 2018, the Company borrowed the remaining $40.0 million, in equal amounts, available under its 5-Year and 7-Year Term Loans, repaid $40.0 million of its Revolving Credit Facility, and concurrently entered into interest rate swap agreements that fixed the interest rates on the additional $40.0 million drawn, resulting in fixed interest rates under the term loans ranging from 4.5790% to 4.6255%. See Note 7 for more details on the interest rate swaps. At March 31, 2018, the Company had drawn the full $100.0 million under the Term Loans which had a fixed weighted average interest rate under the swaps of approximately 4.45%.

The Company’s ability to borrow under the Credit Facility is subject to its ongoing compliance with a number of customary affirmative and negative covenants, including limitations with respect to liens, indebtedness, distributions, mergers, consolidations, investments, restricted payments and asset sales, as well as financial maintenance covenants. Also, the Company’s present financing policy prohibits incurring debt (secured or unsecured) in excess of 40% of its total book capitalization. The Company was in compliance with its financial covenants under its Credit Facility as of March 31, 2018.

XML

Derivative Financial Instruments

3 Months Ended

Mar. 31, 2018

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Financial Instruments

Derivative Financial Instruments

Risk Management Objective of Using Derivatives

The Company may use derivative financial instruments, including interest rate swaps, caps, options, floors and other interest rate derivative contracts, to hedge all or a portion of the interest rate risk associated with its borrowings. The principal objective of such arrangements is to minimize the risks and/or costs associated with the Company’s operating and financial structure as well as to hedge specific anticipated transactions. The Company does not intend to utilize derivatives for speculative or other purposes other than interest rate risk management. The use of derivative financial instruments carries certain risks, including the risk that the counterparties to these contractual arrangements are not able to perform under the agreements. To mitigate this risk, the Company only enters into derivative financial instruments with counterparties with high credit ratings and with major financial institutions with which the Company and its affiliates may also have other financial relationships. The Company does not anticipate that any of the counterparties will fail to meet their obligations.

Cash Flow Hedges of Interest Rate Risk

The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps and/or caps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable-rate amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. Interest rate caps designated as cash flow hedges involve the receipt of variable-rate amounts if interest rates rise above the cap strike rate on the contract.

As of March 31, 2018, the Company had four outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk for notional amounts totaling $100.0 million. The table below presents the fair value of the Company’s derivative financial instruments as well as their classification on the Condensed Consolidated Balance Sheets as of March 31, 2018 and December 31, 2017.

	Asset Derivatives Fair Value at					Liability Derivatives Fair Value at
	March 31, 2018		December 31, 2017		Balance Sheet Classification	March 31, 2018		December 31, 2017		Balance Sheet Classification
Interest rate swaps	$	1,352	$	258	Other assets	$	119	$	—	Other Liabilities

The changes in the fair value of derivatives designated and that qualify as cash flow hedges are recorded in accumulated other comprehensive income and is subsequently reclassified to interest expense in the period that the hedged forecasted transaction affects earnings.

Amounts reported in accumulated other comprehensive income related to derivatives will be reclassified to interest expense as interest payments are made on the Company’s Term Loans. During the next twelve months, the Company estimates that an additional $0.1 million will be reclassified from other comprehensive income ("OCI") as an increase to interest expense.

The table below details the location in the financial statements of the gain or loss recognized on interest rate derivatives designated as cash flow hedges for the three months ended March 31, 2018.

(Dollars in thousands)	Three Months Ended March 31, 2018		Three Months Ended March 31, 2017
Amount of unrealized gain (loss) recognized in OCI on derivative	$	906	$	(158	)
Amount of loss reclassified from accumulated OCI into interest expense	$	68	$	6
Total Interest Expense presented in the Condensed Consolidated Statements of Income in which the effects of the cash flow hedges are recorded	$	1,268	$	597

Credit-risk-related Contingent Features

As of March 31, 2018, the fair value of derivatives in a net liability position including accrued interest but excluding any adjustment for nonperformance risk related to these agreements was $0.1 million. As of March 31, 2018, the Company has not posted any collateral related to these agreements and was not in breach of any agreement provisions. If the Company had breached any of these provisions, it could have been required to settle its obligations under the agreements at their aggregate termination value of approximately $0.1 million at March 31, 2018.

XML

Stockholders' Equity

3 Months Ended

Mar. 31, 2018

Equity [Abstract]

Stockholders' Equity

Stockholders’ Equity

Common Stock

The following table provides a reconciliation of the beginning and ending common stock balances for the three months ended March 31, 2018 and for the year ended December 31, 2017:

	Three Months Ended March 31, 2018	Year Ended December 31, 2017
Balance, beginning of period	18,085,798	12,988,482
Issuance of common stock	—	4,887,500
Restricted stock-based awards	94,001	209,816
Balance, end of period	18,179,799	18,085,798

Equity Offering

On July 26, 2017, the Company completed a public offering of 4,887,500 shares of its common stock, including 637,500 shares of common stock issued in connection with the exercise in full of the underwriters' option to purchase additional shares, and received net proceeds of approximately $108.6 million after deducting underwriting discount and commissions and offering expenses paid by the Company. Proceeds from the offering were used to repay the outstanding balance on our revolving credit facility totaling $58.0 million and for additional investments during 2017.

XML

Net Income Per Common Share

3 Months Ended

Mar. 31, 2018

Earnings Per Share [Abstract]

Net Income Per Common Share

Net Income Per Common Share

The following table sets forth the computation of basic and diluted net income per common share.

	Three Months Ended March 31, 2018
(Dollars in thousands, except per share data)	2018			2017
Net income	$	1,872		$	913
Participating securities' share in earnings	(241		)	—
Net income, less participating securities' share in earnings	$	1,631		$	913
Weighted average Common Shares outstanding
Weighted average Common Shares outstanding	18,164,132			13,089,684
Unvested restricted stock	(590,449		)	(403,501		)
Weighted average Common Shares outstanding–Basic	17,573,683			12,686,183
Weighted average Common Shares outstanding–Basic	17,573,683			12,686,183
Dilutive potential common shares	—			133,313
Weighted average Common Shares outstanding –Diluted	17,573,683			12,819,496
Basic Net Income per Common Share	$	0.09		$	0.07
Diluted Net Income per Common Share	$	0.09		$	0.07

XML

Incentive Plan

3 Months Ended

Mar. 31, 2018

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Incentive Plan

Incentive Plan

Under the Company's 2014 Incentive Plan, awards may be made in the form of restricted stock, cash or a combination of both. Compensation expense recognized from the amortization of the value of the Company's officer, employee and director shares over the applicable vesting periods during the three months ended March 31, 2018 and 2017 was approximately $0.6 million and $0.3 million, respectively.

A summary of the activity under the 2014 Incentive Plan for the three months ended March 31, 2018 and 2017 is included in the table below.

		Three Months Ended March 31,
		2018	2017
Stock-based awards, beginning of period		512,115	302,299
	Stock in lieu of compensation	47,027	59,285
	Stock awards	46,974	57,486
	Total stock granted	94,001	116,771
Stock-based awards, end of period		606,116	419,070

XML

Other Assets

3 Months Ended

Mar. 31, 2018

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]

Other Assets

Other Assets

Other assets consists primarily of notes receivable, accounts and interest receivables, straight-line rent receivables, fair value of interest rate swaps, prepaid assets and deferred financing costs. Items included in "Other assets, net" on the Company's Condensed Consolidated Balance Sheets as of March 31, 2018 and December 31, 2017 are detailed in the table below.

	Balance as of
(Dollars in thousands)	March 31, 2018			December 31, 2017
Notes receivable	$	16,018		$	13,917
Accounts and interest receivables	3,220			2,417
Straight-line rent receivables	2,457			2,179
Allowance for doubtful accounts	(191		)	(293		)
Prepaid assets	294			341
Deferred financing costs, net	721			618
Leasing commissions, net	455			483
Deferred tax asset	610			478
Fair value of interest rate swaps	1,352			258
Other	274			255
	$	25,210		$	20,653

The Company's $16.0 million in notes receivable at March 31, 2018 include mainly the following notes. Interest related to these notes is included in Other Operating Income on the Company's Condensed Consolidated Income Statements.

• During 2017, concurrent with the acquisition of a property, the Company entered into a $5.0 million note receivable with the tenant in the building. The $5.0 million note receivable, which matures on September 27, 2022, currently bears interest at 12% per annum, increasing through the maturity date to 16% per annum, and payments aggregating approximately $1.9 million are due each year until maturity with the remaining amount due at maturity.

• On December 27, 2017, the Company purchased, at a $2.7 million discount to face value, certain promissory notes for $8.75 million which were held by a syndicate of banks that were also creditors of our Borrower. See Note 5 for more details.

• During the first quarter of 2018, the Company acquired $2.2 million of certain promissory notes, secured by the operations of two facilities of our Borrower, which were not included in the bankruptcy. See Note 5 for more details.

The Company identified the borrowers of these notes as VIEs, but management determined that the Company was not the primary beneficiary of the VIEs because we lack either directly or through related parties any material impact in the activities that impact the borrowers' economic performance. We are not obligated to provide support beyond our stated commitment to the borrowers, and accordingly our maximum exposure to loss as a result of this relationship is limited to the amount of our outstanding notes receivable as noted above. The VIEs that we have identified at March 31, 2018 are summarized in the table below.

Classification	Carrying Amount (in millions)		Maximum Exposure to Loss (in millions)
Notes receivable	$	5.0	$	5.0
Notes receivable	$	8.8	$	8.8
Notes receivable	$	1.5	$	1.5
Notes receivable	$	0.7	$	0.7

XML

Fair Value of Financial Instruments

3 Months Ended

Mar. 31, 2018

Fair Value Disclosures [Abstract]

Fair Value of Financial Instruments

Fair Value of Financial Instruments

The following methods and assumptions were used to estimate the fair value of each class of financial instruments for which it is practical to estimate the fair value.

Cash and cash equivalents - The carrying amount approximates the fair value.

Mortgage note receivable - The fair value is estimated using cash flow analyses, based on an assumed market rate of interest or at a rate consistent with the rates on mortgage notes acquired by the Company and are classified as level 2 in the hierarchy.

Notes receivable - The fair value is estimated using cash flow analyses, based on an assumed market rate of interest or at a rate consistent with the rates on notes carried by the Company and are classified as level 2 in the hierarchy.

Borrowings under our Credit Facility - The carrying amount approximates the fair value because the borrowings are based on variable market interest rates.

Interest rate swaps - The fair value is estimated using discounted cash flow techniques. These techniques incorporate primarily level 2 inputs. The market inputs are utilized in the discounted cash flow calculation considering the instrument’s term, notional amount, discount rate and credit risk. Significant inputs to the derivative valuation model for interest rate swaps are observable in active markets and are classified as level 2 in the hierarchy.

The table below details the fair values and carrying values for our mortgage note and notes receivable and interest rate swaps at March 31, 2018 and December 31, 2017, using level 2 inputs.

	March 31, 2018				December 31, 2017
(Dollars in thousands)	Carrying Value		Fair Value		Carrying Value		Fair Value
Mortgage note receivable	$	10,633	$	10,633	$	10,633	$	10,633
Notes receivable	$	16,018	$	16,029	$	13,917	$	13,828
Interest rate swap asset	$	1,352	$	1,352	$	258	$	258
Interest rate swap liability	$	119	$	119	$	—	$	—

XML

Subsequent Events

3 Months Ended

Mar. 31, 2018

Subsequent Events [Abstract]

Subsequent Events

Subsequent Events

Dividend Declared

On May 3, 2018, the Company’s Board of Directors declared a quarterly common stock dividend in the amount of $0.40 per share. The dividend is payable on June 1, 2018 to stockholders of record on May 18, 2018.

XML

Summary of Significant Accounting Policies (Policies)

3 Months Ended

Mar. 31, 2018

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation

The Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. They do not include all of the information and footnotes required by GAAP for complete financial statements.

This interim financial information should be read in conjunction with the financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017.

Management believes that all adjustments of a normal, recurring nature considered necessary for a fair presentation have been included. This interim financial information does not necessarily represent or indicate what the operating results will be for the year ending December 31, 2018. All material intercompany accounts and transactions have been eliminated.

Use of Estimates in the Condensed Consolidated Financial Statements

Use of Estimates in the Condensed Consolidated Financial Statements

Preparation of the Condensed Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect amounts reported in the Condensed Consolidated Financial Statements and accompanying notes. Actual results may materially differ from those estimates.

Income Taxes

Income Taxes

The Company has elected to be taxed as a real estate investment trust ("REIT"), as defined under the Internal Revenue Code of 1986, as amended (the "Code"). The Company and one subsidiary have also elected for that subsidiary to be treated as a taxable REIT subsidiary ("TRS"), which is subject to federal and state income taxes. No provision has been made for federal income taxes for the REIT; however, the Company may record income tax expense or benefit for the TRS to the extent applicable. The Company intends at all times to qualify as a REIT under the Code. The Company must distribute at least 90% per annum of its REIT taxable income to its stockholders (which is computed without regard to the dividends paid deduction or net capital gain and which does not necessarily equal net income as calculated in accordance with GAAP) and meet other requirements to continue to qualify as a REIT.

Effective January 1, 2018, under legislation from the Tax Cuts and Jobs Act of 2017, the maximum U.S. federal corporate income tax rate was reduced from 35% to 21%. Accordingly, to the extent that the activities of our taxable REIT subsidiary generates taxable income in future periods, it may be subject to lower U.S. federal income tax rates.

The Company classifies interest and penalties related to uncertain tax positions, if any, in the Condensed Consolidated Statements of Income as a component of general and administrative expenses.

New Accounting Pronouncements

New Accounting Pronouncements

In May 2014, the FASB issued Accounting Standards Update 2014-09, Revenue from Contracts with Customers ("ASU 2014-09"), which establishes a comprehensive model to account for revenues arising from contracts with customers. ASU 2014-09 applies to all contracts with customers, except those that are within the scope of other topics in the FASB's Accounting Standards Codification, such as real estate leases and financial instruments. ASU 2014-09 requires companies to perform a five-step analysis of transactions to determine when and how revenue is recognized. The Company adopted ASU 2014-09 using the "modified retrospective" method effective January 1, 2018; as such, the Company applied the guidance only to the most recent period presented in the financial statements. The primary source of revenue for the Company is generated through its leasing arrangements with its tenants, which is covered under other accounting guidance, but certain non-lease revenues could be impacted by the new guidance. While the Company has not historically sold any properties, accounting for the sales of real estate could also be impacted by this new guidance. Prior to the adoption of ASU 2014-09, gains and losses from real estate sales were adjusted at the time of the sale by the maximum exposure to loss related to continuing involvement with the real estate. After adoption, any continuing involvement is considered a separate performance obligation and the sales price is required to be allocated between the elements with continuing involvement and those without continuing involvement. As the continuing performance obligations are satisfied, additional gains and losses will be recognized. The Company recognized no change to previously reported amounts from the cumulative effect of the adoption of ASU 2014-09.

On January 1, 2018, the Company adopted ASU No. 2016-15, Statement of Cash Flows (Topic 230) Classification of Certain Cash Receipts and Cash Payments, ("ASU 2016-15"), which clarifies or provides guidance relating to eight specific cash flow classification issues. The standard should be applied retrospectively for each period presented, as appropriate. The impact of this new guidance will depend on future transactions, though the impact will only be related to the classification of those items on the statement of cash flows and will not impact the Company's total cash flows or its results of operations. There was no impact to the Company's Consolidated Financial Statements upon adoption of this standard.

On January 1, 2018, the Company adopted ASU No. 2017-09, Compensation - Stock Compensation (Topic 718), ("ASU 2017-09"), which provides guidance about which changes in the terms or conditions of a share-based payment award require a company to apply modification accounting in Topic 718. Under ASU No. 2017-09, a company will generally be required to apply modification accounting unless the fair value or intrinsic value of the modified award, the vesting conditions of the modified award, and the classification of the modified award as equity or a liability are the same as the original award immediately before the award is modified. There was no impact to the Company's Consolidated Financial Statements upon adoption of this standard.

In February 2016, the FASB issued ASU No. 2016-02, Leases, ("ASU 2016-02"). This standard requires a lessor to classify leases as either sales-type, finance or operating. A lease will be treated as a sale if it transfers all of the risks and rewards, as well as control of the underlying asset, to the lessee. If risks and rewards are conveyed without the transfer of control, the lease is treated as a financing lease. If the lessor doesn’t convey risks and rewards or control, an operating lease results. ASU 2016-02 is effective for fiscal years, and interim periods within, beginning after December 15, 2018. Early adoption is permitted. A modified retrospective transition approach is required for lessors for sales-type, direct financing, and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. Leasing revenues will continue to be recognized on a straight-line basis over the lease term, while certain reimbursable costs currently reflected on a net basis in the financial statements may require presentation on a gross basis under the new standard. Additionally, certain non-lease components may be accounted for under the new revenue recognition guidance in the Revenue ASUs. The Company may also be impacted by this new accounting guidance related to ground leases in which the Company would be the lessee. Pursuant to the new accounting guidance, lessees are required to record a right-of-use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. The Company is still evaluating the complete impact of the adoption of ASU 2016-02 on January 1, 2019 to its consolidated financial position, results of operations and disclosures.

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments-Credit Losses, ("ASU 2016-13"), which changes the impairment model for most financial assets and certain other instruments. For trade and other receivables, held-to-maturity debt securities, loans and other instruments, companies will be required to use a new forward-looking “expected loss” model that generally will result in the earlier recognition of allowances for losses. For available-for-sale debt securities with unrealized losses, companies will measure credit losses in a manner similar to what they do today, except that the losses will be recognized as allowances rather than as reductions in the amortized cost of the securities. Companies will have to disclose significantly more information, including information they use to track credit quality by year of origination for most financing receivables. Companies will apply the standard’s provisions as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is adopted. This standard is effective for the Company on January 1, 2020 with early adoption permitted. The Company is in the initial stage of evaluating the impact of this new standard on its notes and trade receivables.

XML

Real Estate Investments (Tables)

3 Months Ended

Mar. 31, 2018

Real Estate [Abstract]

Schedule of real estate property investments

At March 31, 2018, the Company had investments of approximately $413.3 million in 89 real estate properties, including one mortgage note. The following table summarizes the Company's real estate investments.

(Dollars in thousands)	Number of Facilities	Land and Land Improvements		Buildings, Improvements, and Lease Intangibles		Personal Property		Total		Accumulated Depreciation
Medical office buildings:
Florida	5	$	4,608	$	29,241	$	—	$	33,849	$	2,896
Ohio	5	3,167		23,527		—		26,694		3,951
Texas	3	3,096		13,898		—		16,994		3,579
Illinois	2	1,134		11,823		—		12,957		1,803
Kansas	2	1,427		10,497		—		11,924		2,541
Iowa	1	2,241		9,004		—		11,245		1,412
Other states	14	3,642		27,365		—		31,007		2,898
	32	19,315		125,355		—		144,670		19,080
Physician clinics:
Kansas	3	1,638		10,909		—		12,547		2,157
Illinois	2	2,615		6,354		—		8,969		151
Florida	4	253		9,484		—		9,737		568
Other states	9	3,194		18,472		—		21,666		3,316
	18	7,700		45,219		—		52,919		6,192
Surgical centers and hospitals:
Louisiana	1	1,683		21,353		—		23,036		711
Indiana	1	523		14,405		—		14,928		532
Michigan	2	628		8,272		—		8,900		2,057
Illinois	1	2,183		5,410		—		7,593		847
Florida	1	271		7,017		—		7,288		347
Arizona	2	576		5,389		—		5,965		1,127
Other states	5	1,555		11,000		—		12,555		3,046
	13	7,419		72,846		—		80,265		8,667
Specialty centers:
Illinois	3	3,482		24,717		—		28,199		519
Other states	16	2,609		29,913		—		32,522		4,930
	19	6,091		54,630		—		60,721		5,449
Behavioral facilities:
West Virginia	1	2,138		22,897		—		25,035		298
Illinois	1	1,300		18,803		—		20,103		862
Indiana	2	1,126		6,040		—		7,166		195
Other states	2	977		8,729		—		9,706		159
	6	5,541		56,469		—		62,010		1,514
Corporate property	—	—		2,011		116		2,127		150
Total owned properties	88	$	46,066	$	356,530	$	116	$	402,712	$	41,052
Mortgage note receivable	1	—		—		—		10,633		—
Total real estate investments	89	$	46,066	$	356,530	$	116	$	413,345	$	41,052

XML

Real Estate Leases (Tables)

3 Months Ended

Mar. 31, 2018

Leases [Abstract]

Schedule of future minimum lease payments for operating leases

Future minimum lease payments under the non-cancelable operating leases due the Company for the years ending December 31, as of March 31, 2018, are as follows (in thousands):

2018 (nine months ending December 31)	$	27,856
2019	34,317
2020	31,425
2021	28,128
2022	24,973
2023 and thereafter	147,484
	$	294,183

XML

Debt, net (Tables)

3 Months Ended

Mar. 31, 2018

Debt Disclosure [Abstract]

Schedule of debt

The table below details the Company's debt as of March 31, 2018 and December 31, 2017.

	Balance as of
(Dollars in thousands)	March 31, 2018		December 31, 2017		Maturity Dates
Revolving Credit Facility	$	12,000	$	34,000	8/19
5-Year Term Loan, net	49,703		29,685		3/22
7-Year Term Loan, net	49,682		29,668		3/24
	$	111,385	$	93,353

XML

Derivative Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2018

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of fair value of derivative instruments on balance sheet

The table below presents the fair value of the Company’s derivative financial instruments as well as their classification on the Condensed Consolidated Balance Sheets as of March 31, 2018 and December 31, 2017.

	Asset Derivatives Fair Value at					Liability Derivatives Fair Value at
	March 31, 2018		December 31, 2017		Balance Sheet Classification	March 31, 2018		December 31, 2017		Balance Sheet Classification
Interest rate swaps	$	1,352	$	258	Other assets	$	119	$	—	Other Liabilities

Schedule of derivative gain (loss)

The table below details the location in the financial statements of the gain or loss recognized on interest rate derivatives designated as cash flow hedges for the three months ended March 31, 2018.

(Dollars in thousands)	Three Months Ended March 31, 2018		Three Months Ended March 31, 2017
Amount of unrealized gain (loss) recognized in OCI on derivative	$	906	$	(158	)
Amount of loss reclassified from accumulated OCI into interest expense	$	68	$	6
Total Interest Expense presented in the Condensed Consolidated Statements of Income in which the effects of the cash flow hedges are recorded	$	1,268	$	597

XML

Stockholders' Equity (Tables)

3 Months Ended

Mar. 31, 2018

Equity [Abstract]

Schedule of reconciliation of common stock

The following table provides a reconciliation of the beginning and ending common stock balances for the three months ended March 31, 2018 and for the year ended December 31, 2017:

	Three Months Ended March 31, 2018	Year Ended December 31, 2017
Balance, beginning of period	18,085,798	12,988,482
Issuance of common stock	—	4,887,500
Restricted stock-based awards	94,001	209,816
Balance, end of period	18,179,799	18,085,798

XML

Net Income Per Common Share (Tables)

3 Months Ended

Mar. 31, 2018

Earnings Per Share [Abstract]

Schedule of earnings per share

The following table sets forth the computation of basic and diluted net income per common share.

	Three Months Ended March 31, 2018
(Dollars in thousands, except per share data)	2018			2017
Net income	$	1,872		$	913
Participating securities' share in earnings	(241		)	—
Net income, less participating securities' share in earnings	$	1,631		$	913
Weighted average Common Shares outstanding
Weighted average Common Shares outstanding	18,164,132			13,089,684
Unvested restricted stock	(590,449		)	(403,501		)
Weighted average Common Shares outstanding–Basic	17,573,683			12,686,183
Weighted average Common Shares outstanding–Basic	17,573,683			12,686,183
Dilutive potential common shares	—			133,313
Weighted average Common Shares outstanding –Diluted	17,573,683			12,819,496
Basic Net Income per Common Share	$	0.09		$	0.07
Diluted Net Income per Common Share	$	0.09		$	0.07

XML

Incentive Plan (Tables)

3 Months Ended

Mar. 31, 2018

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Summary of nonvested restricted stock activity

A summary of the activity under the 2014 Incentive Plan for the three months ended March 31, 2018 and 2017 is included in the table below.

		Three Months Ended March 31,
		2018	2017
Stock-based awards, beginning of period		512,115	302,299
	Stock in lieu of compensation	47,027	59,285
	Stock awards	46,974	57,486
	Total stock granted	94,001	116,771
Stock-based awards, end of period		606,116	419,070

XML

Other Assets (Tables)

3 Months Ended

Mar. 31, 2018

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]

Schedule of Other Assets

Items included in "Other assets, net" on the Company's Condensed Consolidated Balance Sheets as of March 31, 2018 and December 31, 2017 are detailed in the table below.

	Balance as of
(Dollars in thousands)	March 31, 2018			December 31, 2017
Notes receivable	$	16,018		$	13,917
Accounts and interest receivables	3,220			2,417
Straight-line rent receivables	2,457			2,179
Allowance for doubtful accounts	(191		)	(293		)
Prepaid assets	294			341
Deferred financing costs, net	721			618
Leasing commissions, net	455			483
Deferred tax asset	610			478
Fair value of interest rate swaps	1,352			258
Other	274			255
	$	25,210		$	20,653

Schedule of VIEs

The VIEs that we have identified at March 31, 2018 are summarized in the table below.

Classification	Carrying Amount (in millions)		Maximum Exposure to Loss (in millions)
Notes receivable	$	5.0	$	5.0
Notes receivable	$	8.8	$	8.8
Notes receivable	$	1.5	$	1.5
Notes receivable	$	0.7	$	0.7

XML

Fair Value of Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2018

Fair Value Disclosures [Abstract]

Fair Value, by Balance Sheet Grouping

The table below details the fair values and carrying values for our mortgage note and notes receivable and interest rate swaps at March 31, 2018 and December 31, 2017, using level 2 inputs.

	March 31, 2018				December 31, 2017
(Dollars in thousands)	Carrying Value		Fair Value		Carrying Value		Fair Value
Mortgage note receivable	$	10,633	$	10,633	$	10,633	$	10,633
Notes receivable	$	16,018	$	16,029	$	13,917	$	13,828
Interest rate swap asset	$	1,352	$	1,352	$	258	$	258
Interest rate swap liability	$	119	$	119	$	—	$	—

XML

Summary of Significant Accounting Policies - Business Overview/Segment Reporting (Details) $ in Thousands, ft² in Millions	3 Months Ended
	Mar. 31, 2018 USD ($) ft² state real_estate_property
Accounting Policies [Abstract]
General partner ownership	100.00%
Value of real estate property investments and mortgages | $	$ 413,345
Number of real estate properties | real_estate_property	89
Number of states in which real estate investments are in | state	27
Area of real estate property (in square feet) | ft²	2.0

XML

Real Estate Investments - Additional Information (Details) $ in Thousands	Mar. 31, 2018 USD ($) mortgage_note_receivable real_estate_property
Real Estate [Line Items]
Value of real estate property investments and mortgages | $	$ 413,345
Number of real estate properties | real_estate_property	89
Number of mortgage note receivables	1
Mortgage Receivable [Member]
Real Estate [Line Items]
Number of mortgage note receivables	1

XML

Real Estate Investments - Schedule of Real Estate Property Investments (Details) $ in Thousands	Mar. 31, 2018 USD ($) mortgage_note_receivable real_estate_property	Dec. 31, 2017 USD ($)
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	89
Land and Land Improvements	$ 46,066	$ 44,419
Buildings, Improvements, and Lease Intangibles	356,530	343,955
Personal Property	116	112
Total real estate properties	402,712	388,486
Accumulated Depreciation	$ 41,052	36,136
Number of mortgage note receivables | mortgage_note_receivable	1
Mortgage note receivable, net	$ 10,633	$ 10,633
Value of real estate property investments and mortgages	$ 413,345
Medical office [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	32
Land and Land Improvements	$ 19,315
Buildings, Improvements, and Lease Intangibles	125,355
Total real estate properties	144,670
Accumulated Depreciation	$ 19,080
Medical office [Member] | Florida [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	5
Land and Land Improvements	$ 4,608
Buildings, Improvements, and Lease Intangibles	29,241
Total real estate properties	33,849
Accumulated Depreciation	$ 2,896
Medical office [Member] | Illinois [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	2
Land and Land Improvements	$ 1,134
Buildings, Improvements, and Lease Intangibles	11,823
Total real estate properties	12,957
Accumulated Depreciation	$ 1,803
Medical office [Member] | Iowa [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	1
Land and Land Improvements	$ 2,241
Buildings, Improvements, and Lease Intangibles	9,004
Total real estate properties	11,245
Accumulated Depreciation	$ 1,412
Medical office [Member] | Kansas [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	2
Land and Land Improvements	$ 1,427
Buildings, Improvements, and Lease Intangibles	10,497
Total real estate properties	11,924
Accumulated Depreciation	$ 2,541
Medical office [Member] | Ohio [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	5
Land and Land Improvements	$ 3,167
Buildings, Improvements, and Lease Intangibles	23,527
Total real estate properties	26,694
Accumulated Depreciation	$ 3,951
Medical office [Member] | Other States [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	14
Land and Land Improvements	$ 3,642
Buildings, Improvements, and Lease Intangibles	27,365
Total real estate properties	31,007
Accumulated Depreciation	$ 2,898
Medical office [Member] | Texas [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	3
Land and Land Improvements	$ 3,096
Buildings, Improvements, and Lease Intangibles	13,898
Total real estate properties	16,994
Accumulated Depreciation	$ 3,579
Physician clinics [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	18
Land and Land Improvements	$ 7,700
Buildings, Improvements, and Lease Intangibles	45,219
Total real estate properties	52,919
Accumulated Depreciation	$ 6,192
Physician clinics [Member] | Florida [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	4
Land and Land Improvements	$ 253
Buildings, Improvements, and Lease Intangibles	9,484
Total real estate properties	9,737
Accumulated Depreciation	$ 568
Physician clinics [Member] | Illinois [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	2
Land and Land Improvements	$ 2,615
Buildings, Improvements, and Lease Intangibles	6,354
Total real estate properties	8,969
Accumulated Depreciation	$ 151
Physician clinics [Member] | Kansas [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	3
Land and Land Improvements	$ 1,638
Buildings, Improvements, and Lease Intangibles	10,909
Total real estate properties	12,547
Accumulated Depreciation	$ 2,157
Physician clinics [Member] | Other States [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	9
Land and Land Improvements	$ 3,194
Buildings, Improvements, and Lease Intangibles	18,472
Total real estate properties	21,666
Accumulated Depreciation	$ 3,316
Surgical Centers and Hospitals [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	13
Land and Land Improvements	$ 7,419
Buildings, Improvements, and Lease Intangibles	72,846
Total real estate properties	80,265
Accumulated Depreciation	$ 8,667
Surgical Centers and Hospitals [Member] | Arizona [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	2
Land and Land Improvements	$ 576
Buildings, Improvements, and Lease Intangibles	5,389
Total real estate properties	5,965
Accumulated Depreciation	$ 1,127
Surgical Centers and Hospitals [Member] | Florida [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	1
Land and Land Improvements	$ 271
Buildings, Improvements, and Lease Intangibles	7,017
Total real estate properties	7,288
Accumulated Depreciation	$ 347
Surgical Centers and Hospitals [Member] | Illinois [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	1
Land and Land Improvements	$ 2,183
Buildings, Improvements, and Lease Intangibles	5,410
Total real estate properties	7,593
Accumulated Depreciation	$ 847
Surgical Centers and Hospitals [Member] | Indiana [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	1
Land and Land Improvements	$ 523
Buildings, Improvements, and Lease Intangibles	14,405
Total real estate properties	14,928
Accumulated Depreciation	$ 532
Surgical Centers and Hospitals [Member] | Louisiana [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	1
Land and Land Improvements	$ 1,683
Buildings, Improvements, and Lease Intangibles	21,353
Total real estate properties	23,036
Accumulated Depreciation	$ 711
Surgical Centers and Hospitals [Member] | Michigan [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	2
Land and Land Improvements	$ 628
Buildings, Improvements, and Lease Intangibles	8,272
Total real estate properties	8,900
Accumulated Depreciation	$ 2,057
Surgical Centers and Hospitals [Member] | Other States [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	5
Land and Land Improvements	$ 1,555
Buildings, Improvements, and Lease Intangibles	11,000
Total real estate properties	12,555
Accumulated Depreciation	$ 3,046
Specialty Centers [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	19
Land and Land Improvements	$ 6,091
Buildings, Improvements, and Lease Intangibles	54,630
Total real estate properties	60,721
Accumulated Depreciation	$ 5,449
Specialty Centers [Member] | Illinois [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	3
Land and Land Improvements	$ 3,482
Buildings, Improvements, and Lease Intangibles	24,717
Total real estate properties	28,199
Accumulated Depreciation	$ 519
Specialty Centers [Member] | Other States [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	16
Land and Land Improvements	$ 2,609
Buildings, Improvements, and Lease Intangibles	29,913
Total real estate properties	32,522
Accumulated Depreciation	$ 4,930
Behavioral facilities [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	6
Land and Land Improvements	$ 5,541
Buildings, Improvements, and Lease Intangibles	56,469
Total real estate properties	62,010
Accumulated Depreciation	$ 1,514
Behavioral facilities [Member] | Illinois [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	1
Land and Land Improvements	$ 1,300
Buildings, Improvements, and Lease Intangibles	18,803
Total real estate properties	20,103
Accumulated Depreciation	$ 862
Behavioral facilities [Member] | Indiana [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	2
Land and Land Improvements	$ 1,126
Buildings, Improvements, and Lease Intangibles	6,040
Total real estate properties	7,166
Accumulated Depreciation	$ 195
Behavioral facilities [Member] | Other States [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	2
Land and Land Improvements	$ 977
Buildings, Improvements, and Lease Intangibles	8,729
Total real estate properties	9,706
Accumulated Depreciation	$ 159
Behavioral facilities [Member] | West Virginia [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	1
Land and Land Improvements	$ 2,138
Buildings, Improvements, and Lease Intangibles	22,897
Total real estate properties	25,035
Accumulated Depreciation	$ 298
Corporate property [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	0
Land and Land Improvements	$ 0
Buildings, Improvements, and Lease Intangibles	2,011
Personal Property	116
Total real estate properties	2,127
Accumulated Depreciation	$ 150
Total Properties [Member]
Real Estate Properties [Line Items]
Number of Facilities | real_estate_property	88
Land and Land Improvements	$ 46,066
Buildings, Improvements, and Lease Intangibles	356,530
Personal Property	116
Total real estate properties	402,712
Accumulated Depreciation	$ 41,052

XML

Real Estate Leases (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017	Dec. 31, 2017
Real Estate [Line Items]
2018 (nine months ending December 31)	$ 27,856
2019	34,317
2020	31,425
2021	28,128
2022	24,973
2023 and thereafter	147,484
Total	294,183
Straight Line rent	415	$ 265
Other Liabilities [Member]
Real Estate [Line Items]
Deferred revenue	$ 1,300		$ 1,100

XML

Real Estate Acquisitions (Details) ft² in Thousands	3 Months Ended
	Mar. 31, 2018 USD ($) ft² real_estate_property
Business Combinations [Abstract]
Number of properties acquired | real_estate_property	3
Area of real estate property (in square feet) | ft²	38
Consideration transferred	$ 12,700,000
Percentage of properties that were leased at acquisition	100.00%
Revenue from properties acquired	$ 20,230
Net income from properties acquired	13,415
Transaction costs	$ 101,000

XML

Mortgage Note Receivable (Details) $ in Thousands			3 Months Ended		12 Months Ended
	Apr. 25, 2018 USD ($) hospital	Dec. 28, 2017 USD ($) real_estate_property	Mar. 31, 2018 USD ($) mortgage_note_receivable	Mar. 31, 2017 USD ($)	Dec. 31, 2017 USD ($) real_estate_property	Dec. 27, 2017 USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of mortgage note receivables | mortgage_note_receivable			1
Mortgage note receivable, net			$ 10,633		$ 10,633
Notes receivable			16,018		13,917
Proceeds from the repayment of notes receivable			17	$ 140
Funding of notes receivable			2,201	$ 0
Real estate property			$ 361,660		352,350
Mortgage Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of mortgage note receivables | mortgage_note_receivable			1
Promissory Notes, Secured by Accounts Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Mortgage loans on real estate, face amount of mortgages		$ 11,450
Notes receivable		8,750				$ 8,750
Receivable with imputed interest, discount		$ 2,700				$ 2,700
Promissory Notes, Secured By Facilities Owned By Borrower [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Notes receivable			$ 2,200
Notes Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Notes receivable					$ 5,000
Other Assets [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest receivable			$ 600
Subsequent Event [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Repayments of mortgage note payable	$ 6,700
Subsequent Event [Member] | Notes Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Proceeds from the repayment of notes receivable	10,950
Funding of notes receivable	23,000
Proceeds from the repayment of notes receivable, interest	261
Proceeds from the repayment of notes receivable, fees and expenses	$ 250
Long-Term Acute Care Facility [Member] | Subsequent Event [Member] | Notes Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of properties used to secure notes by borrower | hospital	7
Specialty Hospital [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of properties used to secure notes by borrower | real_estate_property		2			2
Specialty Hospital [Member] | Subsequent Event [Member] | Notes Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of properties used to secure notes by borrower | hospital	1
Property Previously Financed By Mortgage Receivable [Member] | Subsequent Event [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Real estate property	$ 4,500

XML

Debt, net - Schedule of Debt (Details) - USD ($) $ in Thousands	Mar. 31, 2018	Dec. 31, 2017
Debt Instrument [Line Items]
Debt, net	$ 111,385	$ 93,353
Term Loan [Member] | Second Amended And Restated Credit Facility [Member]
Debt Instrument [Line Items]
Debt, net	100,000
Revolving Credit Facility [Member] | Line of Credit [Member] | Second Amended And Restated Credit Facility [Member]
Debt Instrument [Line Items]
Debt, net	12,000	34,000
5 Year Term Loan [Member] | Term Loan [Member] | Second Amended And Restated Credit Facility [Member]
Debt Instrument [Line Items]
Debt, net	49,703	29,685
7 Year Term Loan [Member] | Term Loan [Member] | Second Amended And Restated Credit Facility [Member]
Debt Instrument [Line Items]
Debt, net	$ 49,682	$ 29,668

XML

Debt, net - Narrative (Details)				3 Months Ended
	Mar. 29, 2018 USD ($)	Jul. 26, 2017 USD ($)	Mar. 29, 2017 USD ($) option	Mar. 31, 2018 USD ($)	Mar. 31, 2017 USD ($)	Mar. 27, 2018 USD ($)	Mar. 26, 2018 USD ($)	Dec. 31, 2017 USD ($)
Line of Credit Facility [Line Items]
Debt issuance costs				$ 218,000	$ 766,000
Amount outstanding				111,385,000				$ 93,353,000
Draw on term loan borrowings				$ 40,000,000	$ 60,000,000
Revolving Credit Facility [Member] | Line of Credit [Member]
Line of Credit Facility [Line Items]
Debt repaid	$ 40,000,000	$ 58,000,000
Swingline Commitment [Member] | Line of Credit [Member]
Line of Credit Facility [Line Items]
Maximum borrowing capacity						$ 20,000,000	$ 15,000,000
Second Amended And Restated Credit Facility [Member]
Line of Credit Facility [Line Items]
Maximum percentage of total book capitalization				40.00%
Second Amended And Restated Credit Facility [Member] | Term Loan [Member]
Line of Credit Facility [Line Items]
Face amount			$ 100,000,000
Unused borrowing commitment fee percentage			0.35%
Amount outstanding				$ 100,000,000
Draw on term loan borrowings	$ 40,000,000
Weighted average interest rate percentage				4.45%
Second Amended And Restated Credit Facility [Member] | Minimum [Member] | Term Loan [Member]
Line of Credit Facility [Line Items]
Fixed rate	4.579%
Second Amended And Restated Credit Facility [Member] | Maximum [Member] | Term Loan [Member]
Line of Credit Facility [Line Items]
Fixed rate	4.6255%
Second Amended And Restated Credit Facility [Member] | London Interbank Offered Rate (LIBOR) [Member] | Minimum [Member] | Term Loan [Member]
Line of Credit Facility [Line Items]
Variable rate percentage			1.95%
Second Amended And Restated Credit Facility [Member] | London Interbank Offered Rate (LIBOR) [Member] | Maximum [Member] | Term Loan [Member]
Line of Credit Facility [Line Items]
Variable rate percentage			2.65%
Second Amended And Restated Credit Facility [Member] | Base Rate [Member] | Minimum [Member] | Term Loan [Member]
Line of Credit Facility [Line Items]
Variable rate percentage			0.95%
Second Amended And Restated Credit Facility [Member] | Base Rate [Member] | Maximum [Member] | Term Loan [Member]
Line of Credit Facility [Line Items]
Variable rate percentage			1.65%
Second Amended And Restated Credit Facility [Member] | Revolving Credit Facility [Member] | Line of Credit [Member]
Line of Credit Facility [Line Items]
Maximum borrowing capacity			$ 150,000,000
Number of options to extend | option			2
Amount outstanding				$ 12,000,000				34,000,000
Remaining borrowing capacity				138,000,000
Second Amended And Restated Credit Facility [Member] | Revolving Credit Facility [Member] | London Interbank Offered Rate (LIBOR) [Member] | Minimum [Member] | Line of Credit [Member]
Line of Credit Facility [Line Items]
Variable rate percentage			1.75%
Second Amended And Restated Credit Facility [Member] | Revolving Credit Facility [Member] | London Interbank Offered Rate (LIBOR) [Member] | Maximum [Member] | Line of Credit [Member]
Line of Credit Facility [Line Items]
Variable rate percentage			2.50%
Second Amended And Restated Credit Facility [Member] | Revolving Credit Facility [Member] | Base Rate [Member] | Minimum [Member] | Line of Credit [Member]
Line of Credit Facility [Line Items]
Variable rate percentage			0.75%
Second Amended And Restated Credit Facility [Member] | Revolving Credit Facility [Member] | Base Rate [Member] | Maximum [Member] | Line of Credit [Member]
Line of Credit Facility [Line Items]
Variable rate percentage			1.50%
Second Amended And Restated Credit Facility [Member] | Credit Facility, Accordion Feature [Member]
Line of Credit Facility [Line Items]
Maximum borrowing capacity			$ 450,000,000
Second Amended And Restated Credit Facility [Member] | 5 Year Term Loan [Member] | Term Loan [Member]
Line of Credit Facility [Line Items]
Face amount			$ 50,000,000
Debt term			5 years
Amount outstanding				49,703,000				29,685,000
Second Amended And Restated Credit Facility [Member] | 7 Year Term Loan [Member] | Term Loan [Member]
Line of Credit Facility [Line Items]
Face amount			$ 50,000,000
Debt term			7 years
Amount outstanding				$ 49,682,000				$ 29,668,000
Second Amended And Restated Credit Facility [Member] | Revolving Credit Facility, Unused Borrowing Capacity Rate 1 [Member] | Line of Credit [Member]
Line of Credit Facility [Line Items]
Unused borrowing commitment fee percentage			0.25%
Percentage of borrowing capacity outstanding			33.30%
Second Amended And Restated Credit Facility [Member] | Revolving Credit Facility, Unused Borrowing Capacity Rate 2 [Member] | Line of Credit [Member]
Line of Credit Facility [Line Items]
Unused borrowing commitment fee percentage			0.35%
Percentage of borrowing capacity outstanding			33.30%

XML

Derivative Financial Instruments - Narrative (Details) $ in Millions	3 Months Ended
	Mar. 31, 2018 USD ($) derivative_instrument
Derivative [Line Items]
Cash flow hedges reclassified to interest expense	$ 0.1
Cash Flow Hedging [Member] | Interest Rate Contract [Member]
Derivative [Line Items]
Number outstanding interest rate derivatives | derivative_instrument	4
Notional amount	$ 100.0
Fair value of derivatives in net asset position	0.1
Aggregate termination value	$ 0.1

XML

Derivative Financial Instruments - Fair Value Balance Sheet (Details) - USD ($) $ in Thousands	Mar. 31, 2018	Dec. 31, 2017
Derivatives, Fair Value [Line Items]
Derivative asset	$ 1,352	$ 258
Cash Flow Hedging [Member] | Interest Rate Swap [Member] | Designated as Hedging Instrument [Member] | Other Assets [Member]
Derivatives, Fair Value [Line Items]
Derivative asset	1,352	258
Cash Flow Hedging [Member] | Interest Rate Swap [Member] | Designated as Hedging Instrument [Member] | Other Liabilities [Member]
Derivatives, Fair Value [Line Items]
Derivative liability	$ 119	$ 0

XML

Derivative Financial Instruments - Cash Flow Hedging (Details) - Interest Rate Contract [Member] - Cash Flow Hedging [Member] - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Derivative Instruments, Gain (Loss) [Line Items]
Amount of unrealized gain (loss) recognized in OCI on derivative	$ 906	$ (158)
Amount of loss reclassified from accumulated OCI into interest expense	68	6
Total Interest Expense presented in the Condensed Consolidated Statements of Income in which the effects of the cash flow hedges are recorded	$ 1,268	$ 597

XML

Stockholders' Equity - Reconciliation of Common Stock (Details) - shares	3 Months Ended	12 Months Ended
	Mar. 31, 2018	Dec. 31, 2017
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning of period (in shares)	18,085,798	12,988,482
Issuance of common stock (in shares)	0	4,887,500
Restricted stock-based awards (in shares)	94,001	209,816
Balance, end of period (in shares)	18,179,799	18,085,798

XML

Stockholders' Equity - Equity Offering (Details) - USD ($) $ in Millions	Mar. 29, 2018	Jul. 26, 2017
Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Proceeds from sale of stock		$ 108.6
Public Offering [Member] | Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Shares issued in transaction (shares)		4,887,500
Over-Allotment Option [Member] | Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Shares issued in transaction (shares)		637,500
Revolving Credit Facility [Member] | Line of Credit [Member]
Subsidiary, Sale of Stock [Line Items]
Debt repaid	$ 40.0	$ 58.0

XML

Net Income Per Common Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Earnings Per Share [Abstract]
Net income	$ 1,872	$ 913
Participating securities' share in earnings	(241)	0
Net income, less participating securities' share in earnings	$ 1,631	$ 913
Weighted average Common Shares outstanding
Weighted average Common Shares outstanding (in shares)	18,164,132	13,089,684
Unvested restricted stock (in shares)	(590,449)	(403,501)
Weighted average Common Shares outstanding–Basic (in shares)	17,573,683	12,686,183
Weighted average Common Shares outstanding–Basic (in shares)	17,573,683	12,686,183
Dilutive effect of restricted stock (in shares)	0	133,313
Weighted average Common Shares outstanding –Diluted (in shares)	17,573,683	12,819,496
Basic Net Income per Common Share (in dollars per share)	$ 0.09	$ 0.07
Diluted Net Income per Common Share (in dollars per share)	$ 0.09	$ 0.07

XML

Incentive Plan - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
2014 Incentive Plan [Member] | Restricted Common Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	$ 0.6	$ 0.3

XML

Incentive Plan - Restricted Stock Activity (Details) - 2014 Incentive Plan [Member] - shares	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Restricted Common Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Stock-based awards, beginning of period (in shares)	512,115	302,299
Granted (in shares)	94,001	116,771
Stock-based awards, end of period (in shares)	606,116	419,070
Restricted Common Stock, Stock in Lieu of Compensation [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Granted (in shares)	47,027	59,285
Restricted Common Stock, Stock Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Granted (in shares)	46,974	57,486

XML

Other Assets - Other Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2018	Dec. 31, 2017
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Notes receivable	$ 16,018	$ 13,917
Accounts and interest receivables	3,220	2,417
Straight-line rent receivables	2,457	2,179
Allowance for doubtful accounts	(191)	(293)
Prepaid assets	294	341
Deferred financing costs, net	721	618
Leasing commissions, net	455	483
Deferred tax asset	610	478
Fair value of interest rate swaps	1,352	258
Other	274	255
Other assets, net	$ 25,210	$ 20,653

XML

Other Assets - Narrative (Details) $ in Thousands		12 Months Ended
	Dec. 28, 2017 USD ($) real_estate_property	Dec. 31, 2017 USD ($) real_estate_property	Mar. 31, 2018 USD ($)	Dec. 27, 2017 USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Notes receivable		$ 13,917	$ 16,018
Note receivable, payments due		1,900
Notes Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Notes receivable		$ 5,000
Promissory Notes, Secured by Accounts Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Notes receivable	$ 8,750			$ 8,750
Receivable with imputed interest, discount	$ 2,700			$ 2,700
Promissory Notes, Secured By Facilities Owned By Borrower [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Notes receivable			$ 2,200
Minimum [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Note receivable interest rate		12.00%
Maximum [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Note receivable interest rate		16.00%
Specialty Hospital [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of properties used to secure notes by borrower | real_estate_property	2	2

XML

Other Assets - VIEs (Details) - Variable Interest Entity, Not Primary Beneficiary [Member] $ in Millions	Mar. 31, 2018 USD ($)
Notes Receivable [Member]
Variable Interest Entity [Line Items]
Carrying Amount	$ 5.0
Maximum Exposure to Loss	5.0
Promissory Notes, Secured by Accounts Receivable [Member]
Variable Interest Entity [Line Items]
Carrying Amount	8.8
Maximum Exposure to Loss	8.8
Promissory Notes, Secured By Facilities Owned By Borrower 1 [Member]
Variable Interest Entity [Line Items]
Carrying Amount	1.5
Maximum Exposure to Loss	1.5
Promissory Notes, Secured By Facilities Owned By Borrower 2 [Member]
Variable Interest Entity [Line Items]
Carrying Amount	0.7
Maximum Exposure to Loss	$ 0.7

XML

Fair Value of Financial Instruments (Details) - USD ($) $ in Thousands	Mar. 31, 2018	Dec. 31, 2017
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Mortgage note receivable	$ 10,633	$ 10,633
Notes receivable	16,018	13,917
Interest rate swap asset	1,352	258
Carrying Value [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Mortgage note receivable	10,633	10,633
Notes receivable	16,018	13,917
Carrying Value [Member] | Interest Rate Swap [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest rate swap asset	1,352	258
Interest rate swap liability	119	0
Fair Value [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Mortgage note receivable	10,633	10,633
Notes receivable	16,029	13,828
Fair Value [Member] | Interest Rate Swap [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest rate swap asset	1,352	258
Interest rate swap liability	$ 119	$ 0

XML

Subsequent Events (Details) - $ / shares		3 Months Ended
	May 03, 2018	Mar. 31, 2018	Mar. 31, 2017
Subsequent Event [Line Items]
Dividend declared (in dollars per share)		$ 0.3975	$ 0.3875
Subsequent Event [Member]
Subsequent Event [Line Items]
Dividend declared (in dollars per share)	$ 0.40